###begin article-title 0
An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia
###end article-title 0
###begin p 1
###xml 964 971 964 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
The transcription factor Hypoxia-inducible factor 1 (HIF-1) plays a central role in the transcriptional response to oxygen flux. To gain insight into the molecular pathways regulated by HIF-1, it is essential to identify the downstream-target genes. We report here a strategy to identify HIF-1-target genes based on an integrative genomic approach combining computational strategies and experimental validation. To identify HIF-1-target genes microarrays data sets were used to rank genes based on their differential response to hypoxia. The proximal promoters of these genes were then analyzed for the presence of conserved HIF-1-binding sites. Genes were scored and ranked based on their response to hypoxia and their HIF-binding site score. Using this strategy we recovered 41% of the previously confirmed HIF-1-target genes that responded to hypoxia in the microarrays and provide a catalogue of predicted HIF-1 targets. We present experimental validation for ANKRD37 as a novel HIF-1-target gene. Together these analyses demonstrate the potential to recover novel HIF-1-target genes and the discovery of mammalian-regulatory elements operative in the context of microarray data sets.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 488 489 481 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 779 782 768 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2 B3 B4 B5">2&#8211;5</xref>
###xml 894 897 879 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</italic>
###xml 924 925 909 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1075 1078 1060 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6 B7 B8 B9">6&#8211;9</xref>
###xml 1226 1232 1208 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CREBBP</italic>
###xml 1233 1238 1215 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EP300</italic>
###xml 1568 1570 1550 1552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
Maintenance of oxygen homeostasis in mammalian cells is fundamental to the survival of the organism. One of the pivotal mediators of the cellular response to hypoxia is hypoxia-inducible factor (HIF), a transcription factor that contains a basic helix-loop-helix motif as well as PAS domain. There are three known members of the HIF family (HIF-1, HIF-2 and HIF-3) and all are alpha/beta heterodimeric proteins. HIF-1 was the first factor to be cloned and is the best understood isoform (1). HIF-3 is a distant relative of HIF-1 and little is currently known about its function and involvement in oxygen homeostasis. HIF-2, however, is closely related to HIF-1 and both activate hypoxia-dependent gene transcription. In all three isoforms the alpha-subunit senses oxygen levels (2-5). In normoxia the alpha-subunit is ubiquitously expressed but is rapidly degraded through interaction with the VHL ubiquitin ligase complex (6). In hypoxic conditions, it is stabilized through multiple mechanisms that are transcriptional, post-transcriptional, as well as post-translational (6-9). The beta-subunit is widely expressed and generally not regulated by hypoxia. Once stabilized HIF-1 and HIF-2 interact with co-activators such as CREBBP/EP300 and bind to a consensus sequence element (5'-RCGTG-3') in the proximal promoters of hypoxia-regulated genes. Together these genes control cellular process including a switch from oxidative to glycolytic metabolism, inhibition of cellular proliferation, and stimulation of oxygen delivery through erythropoiesis and angiogenesis (10). Metabolic deregulation is the final outcome if the adaptive response is inadequate.
###end p 3
###begin p 4
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 541 546 541 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF1A</italic>
###xml 581 586 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EPAS1</italic>
###xml 669 671 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 672 674 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 769 771 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 772 774 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
Hypoxia can arise in a variety of developmental, physiological and pathological states. Solid tumors, such as breast cancer, quickly outgrow their blood supply and manipulate the hypoxia pathways to promote their own survival. The role of HIF-1 in tumor onset, progression, invasion and metastasis has been demonstrated in several solid tumors (11,12). In addition, cancer specific-regulatory roles for HIF-2 have been demonstrated in an expanding list of cancers (13). For instance, in clear renal cell carcinoma the normal predominance of HIF1A expression is altered in favor of EPAS1 (HIF2alpha) expression and promotes prosurvival rather than proapoptotic factors (14,15). As a result HIF-target genes have emerged as potential targets for cancer specific therapy (16,17).
###end p 4
###begin p 5
###xml 185 189 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDK1</italic>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 302 308 302 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN1A</italic>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
HIF-1 is an important metabolic regulator that allows rapid adaptation to oxygen availability. This effect is mediated through key regulators of bioenergetics and growth. For instance, PDK1 is directly induced by HIF-1 resulting in attenuation of mitochondrial function and oxygen consumption (18) and CDKN1A is induced leading to growth arrest at the G1 phase (19). Identifying such HIF-target genes is central to our understanding of the HIF network and the mechanism of cellular pathways modulation during hypoxia. In addition, identifying additional binding sites in HIF-regulated genes might contribute to the paradigm of inferring function from sequence.
###end p 5
###begin p 6
###xml 373 377 373 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDK1</italic>
###xml 519 523 519 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDK1</italic>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 615 637 615 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 857 862 857 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 865 867 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1165 1170 1165 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF1A</italic>
###xml 1175 1180 1175 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EPAS1</italic>
###xml 1202 1207 1198 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1210 1212 1206 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 615 637 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 834 839 <span type="species:ncbi:9606">human</span>
###xml 901 906 <span type="species:ncbi:9606">human</span>
Currently, studies attempting to identify novel HIF-target genes rely on microarray expression profiles to detect genes that respond to changes in HIF protein levels. Typically a gene of interest is selected and experimentally validated for HIF binding to its promoter. Kim et al. identified 25 transcripts that increase by at least 4-fold during hypoxia in a B cell line. PDK1 was selected for further validation due to its role in regulating the TCA cycle. Consequently they were able to show that HIF-1 binds to the PDK1 promoter (18). Shen et al. (20) used a more rationale microarray design where tissues from Caenorhabditis elegans were profiled in normoxia and in hypoxia in a wild-type, HIF-1 knockout and a VHL mutant strain. This study resulted in 63 HIF-1 dependent genes that respond to hypoxia but only 12 of those had a human homolog. Elvidge et al. (21) compared expression profiles of human breast cancer cells in normoxia, hypoxia and in normoxia treated with a 2-OG-dependent dioxygenase inhibitor, dimethyloxalylglycine (DMOG) which activates HIF-1. In addition, they compared expression profiles in hypoxia and in hypoxia treated with siRNAs to HIF1A and EPAS1 (HIF-2alpha). Manalo et al. (22) profiled arterial endothelial cells in normoxia and in hypoxia as well as in normoxia in the presence of a HIF-1alpha constitutively active form. Only 45 genes were identified in both studies as HIF-1 dependent. Although these approaches are more likely to filter out genes that are not dependent on HIF-1, it remains challenging to determine whether the affected transcripts were directly or indirectly modulated by HIF.
###end p 6
###begin p 7
###xml 20 29 20 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-silico</italic>
###xml 110 115 110 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23 B24 B25 B26 B27 B28 B29">23&#8211;29</xref>
###xml 248 255 248 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 553 558 553 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 1015 1024 1015 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-silico</italic>
###xml 1482 1484 1482 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1485 1490 1485 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34 B35 B36">34&#8211;36</xref>
###xml 1501 1504 1501 1504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1613 1615 1613 1615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 995 1000 <span type="species:ncbi:9606">human</span>
Several methods for in-silico identification of transcription factor-binding sites (TFBS) have been proposed (23-29). These methods fall into two categories. First, identification of TFBS based on predefined position weight matrices (PWM). Second, de novo prediction of sequence motifs over-represented in proximal promoters compared to control sequences [for a review, see (30,31)]. Examples for the former include STORM in CREAD (27), CORE_TF (28) and GeneAct (29) and for the latter DME (32) and the genomic identification of motifs described by Xie et al. (26). PWMs of HIF-1 have been previously used to identify genome-wide target genes. For instance, the Gene Set Enrichment Analysis program contains a set of HIF-1-target genes as part of its Molecular Signature Database (26,33). However, these approaches do not take into consideration promoter availability. In addition, the consensus HIF-binding sequence is very short, has low information content and is ubiquitously present in the human genome making in-silico genome-wide prediction unreliable. To generate a reliable prediction we propose to reduce the search space to a subset of genes expressed in specific tissues under specific conditions. This can be achieved by microarray expression profiles under the assumption that promoters of genes that respond to a stimulus are available for TF binding. Several groups previously demonstrated that microarray expression profiles can be used to improve TFBS prediction (32,34-36) and that cis-regulatory modules in proximal promoters correlate with differential expression of downstream-target genes (27).
###end p 7
###begin p 8
###xml 331 338 331 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
In this study we present an integrative genomic approach combining both computational and experimental strategies to identify HIF-target genes. Using this approach we recovered 41% of the known HIF-1-target genes that were differentially expressed in hypoxia, defined a ranked list of HIF-target genes and experimentally validated ANKRD37 as a novel HIF-1 target.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Microarrays
###end title 10
###begin p 11
###xml 43 45 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 570 571 570 571 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 1044 1045 1044 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1107 1109 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
Raw microarray data was obtained from GEO (37) and ArrayExpress (38). Microarray studies were filtered to identify those that profiled the same tissue in normoxia and hypoxia on Affymetrix platform and used at least two replicates and provided raw data. Affymetrix-based data sets were normalized using the GCRMA module (39) of bioconductor (40) and present-absent calls were calculated for each probe using the MAS5 module. All probes with no present calls were removed and from the remaining at least one sample was required to have an expression value larger than log2 (100), as recommended by Affymetrix. In all experiments, only pairwise comparisons were made with respect to normoxia. After the initial filtering was applied, the expression values were centered to the mean for each probe with replicates. Only probes for which the expression values of the replicates were all positive or all negative were further tested for differential expression. The Limma module (41) of biocoductor was used to fit a linear model for each probe and P-values were corrected using the false discovery rate method (42).
###end p 11
###begin title 12
Promoters
###end title 12
###begin p 13
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 22 27 <span type="species:ncbi:9606">human</span>
Promoter sequences of human genome build 18 were obtained from UCSC genome browser (43). For each protein-coding gene, the proximal promoter was defined as 700 bases upstream and 300 bases downstream of the transcription start site. In cases where multiple transcripts were annotated all alternative promoters were obtained and analyzed individually. Due to restriction of conservation analysis programs, for all genes the forward strand sequence of the genome was used. Background promoters for enrichment analysis were selected randomly from the promoter collection to match the CpG content and base composition of the foreground promoters. We obtained CpG sequence location from UCSC genome browser (43) and matched their location to the promoters defined. Each promoter was classified as CpG or non-CpG and for the background set the same proportion of CpG and non CpG promoters were selected randomly according to the ratio in the foreground set. Next we verified that the base composition matched within +/-2% for each nucleotide with the foreground data set. For all enrichment purposes a set of 1000 promoters was used as a background.
###end p 13
###begin title 14
Enrichment of binding sites
###end title 14
###begin p 15
###xml 30 32 30 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 296 297 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The program MOTIFCLASS v1.40 (27) was employed to identify binding sites over-represented in promoters of a foreground set (genes differentially expressed in microarrays) compared to a background set of 1000 randomly selected promoters. The relative error-rate was optimized for each motif and a P-value was calculated using 10 000 permutations. Finally, only motifs with an enrichment specificity of at least 0.5 were reported.
###end p 15
###begin title 16
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">De-novo</italic>
De-novo prediction of motifs
###end title 16
###begin p 17
###xml 24 26 24 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 27 29 27 29 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
The program DME (v2.0) (27,32) was employed using the ZOOPS model to identify motifs of length 5-12 bases compared to a background set. Only the top 50 enriched motifs were reported and compared to known motifs using the program MATCOMPARE in CREAD (27).
###end p 17
###begin title 18
Binding site prediction
###end title 18
###begin p 19
###xml 28 30 28 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 31 33 31 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 98 99 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</italic>
###xml 176 177 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 181 182 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</italic>
###xml 286 287 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 291 292 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</italic>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 628 629 628 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 820 821 820 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1142 1143 1142 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1341 1343 1341 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 1354 1359 <span type="species:ncbi:9606">human</span>
###xml 1368 1378 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1428 1438 <span type="species:ncbi:9395">tree shrew</span>
###xml 1450 1455 <span type="species:ncbi:10090">mouse</span>
###xml 1463 1466 <span type="species:ncbi:10116">rat</span>
###xml 1474 1484 <span type="species:ncbi:10141">guinea pig</span>
###xml 1496 1502 <span type="species:ncbi:9986">rabbit</span>
###xml 1551 1554 <span type="species:ncbi:9615">dog</span>
###xml 1566 1569 <span type="species:ncbi:9685">cat</span>
###xml 1581 1586 <span type="species:ncbi:9796">horse</span>
###xml 1598 1601 <span type="species:ncbi:9913">cow</span>
###xml 1634 1642 <span type="species:ncbi:99490|species:ncbi:9783|species:ncbi:9785">elephant</span>
###xml 1691 1699 <span type="species:ncbi:9258">platypus</span>
###xml 1729 1736 <span type="species:ncbi:9031">chicken</span>
###xml 1820 1826 <span type="species:ncbi:8090">medaka</span>
###xml 1841 1850 <span type="species:ncbi:7955">zebrafish</span>
The program STORM in CREAD (27,44) was used to match PWMs to genomic DNA and was employed using a P-value cutoff of 1e-4. This cutoff was found to be optimal since a cutoff of P < 1e-3 was not stringent enough predicting nearly every promoter in the genome as having a HIF-1 site while P < 1e-5 was too stringent predicting only a handful of promoters in the genome with a HIF-1 site. Conservation information of 28 species genome alignments (43) was used in two approaches. First, the software multiSTORM [also in CREAD (27)] was employed to identify the number of genomes in which the PWM could still be matched with the same P-value cutoff as used in STORM. Second, the software site-cons was employed to calculate the level of conservation at each binding site compared to the flanking 100 bases (27). The site-cons P-value was obtained by extracting 100 bases upstream and downstream of the binding site and sampling randomly a number of columns equal to the length of the predicted binding site. A conservation score was then calculated for these columns and the process was iterated 10 000 times to obtain a distribution. Finally, the P-value was calculated by comparing the original score for the binding site to the distribution. Conservation information was obtained from the 28-genome alignments available at UCSC genome browser (43). Namely, human (hg18), chimpanzee (panTro2), rhesus (rheMac2), bushbaby (otoGar1), tree shrew (tupBel1), mouse (mm8), rat (rn4), guinea pig (cavPor2), rabbit (oryCun1), shrew (sorAra1), hedgehog (eriEur1), dog (canFam2), cat (felCat3), horse (equCab1), cow (bosTau3), armadillo (dasNov1), elephant (loxAfr1), tenrec (echTel1), opossum (monDom4), platypus (ornAna1), lizard (anoCar1), chicken (galGal3), frog (xenTro2), fugu (fr2), tetraodon (tetNig1), stickleback (gasAcu1), medaka (oryLat1) and zebrafish (danRer4).
###end p 19
###begin title 20
Transcription network
###end title 20
###begin p 21
###xml 242 243 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 966 967 954 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1010 1011 998 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1037 1038 1025 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
For each predicted HIF-target gene, the single best scoring HIF site was selected and other binding sites were identified within +/-25, +/-50, +/-75, +/-100, +/-125 and +/-150 bases of that site as well as in the entire promoter. To obtain a P-value the frequency of each site within that window was compared to a randomly selected background set of 1000 promoters from genes that respond to hypoxia but had no detectable HIF-binding site. Sequence composition for the foreground and background set were matched as described above. In each of the background promoters a single binding site was randomly selected and binding sites were identified within the window size as selected for the HIF site. A chi-square test was performed for each TF, comparing the occurrence of binding sites in the neighborhood of HIF to their occurrence in the neighborhood of the randomly selected binding site in the background set. This process was iterated 100 times and the average P-value for each TFBS was used as the final P-value. No correction for P-values was performed.
###end p 21
###begin title 22
Functional pathway analysis
###end title 22
###begin p 23
###xml 32 34 32 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 638 639 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 764 766 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 904 906 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 1089 1091 1089 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 1331 1333 1331 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 1009 1014 <span type="species:ncbi:9606">human</span>
###xml 1165 1170 <span type="species:ncbi:9606">human</span>
The KEGG database (release 47) (45) was obtained and used to place predicted HIF-target genes into molecular pathways. Statistical analysis was performed using a hypergeometric distribution as described in the GOhyperGAll module of Bioconductor for gene ontology terms (40). The R program was employed (v2.6.2) with the following command: phyper(x - 1, m, n-m, k and lower.tail = FALSE), where x is the number of predicted target gene within a specific pathway; m, the number of genes in that pathway; n total number of unique genes in KEGG; and k, the number of predicted HIF-target genes that have an entry in any of the KEGG pathways. P-values were not corrected for multiple testing. This statistical analysis was repeated using the Reactome pathway database (46), the curated gene sets of Gene Set Enrichment Molecular Signature database (33) and the microRNA predicted targets database TargetScan (47). Enrichment for protein interactions was performed by first compiling a list of interactors for each human protein (Data obtained from NCBI Gene database). The HomoloGene database (48) was used to identify interaction in other species that can be mapped to human proteins. Finally, enrichment was calculated as described for KEGG by considering all interactors of each protein. Protein domains were obtained from Interpro (49) and enrichment was calculated for each domain.
###end p 23
###begin title 24
Selection of mitochondrial genes
###end title 24
###begin p 25
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 77 82 <span type="species:ncbi:9606">human</span>
Genes that localize to the mitochondria were selected by identifying (i) all human Swiss-Prot proteins annotated as localized to the mitochondria (50); (ii) genes annotated with Gene Ontology terms that include the keywords: mitochondria, mitochondrion or mitochondrial (51); and (iii) A predicted catalog of genes localized to the mitochondria (52). Genes from the predicted list of mitochondrial genes that conflicted with existing knowledge and annotation were removed.
###end p 25
###begin title 26
Cell culture
###end title 26
###begin p 27
###xml 317 318 317 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 325 326 325 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 336 337 336 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 145 151 <span type="species:ncbi:9913">bovine</span>
DLD-1, HCT116, SW480, Lovo, Panc-1, HeLa and MCF7 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Hypoxic conditions were achieved by culturing cell lines in a sealed hypoxia chamber (Billups-Rothenberg) for 18 h after flushing with a mixture of 1% O2, 5% CO2 and 94% N2 (Compressed pre-mixed gas, Airgas) (53). To minimize the effect of serum growth factors, the culture medium was switched to serum-free UltraCulture (Lonza) before the cells were subjected to hypoxia.
###end p 27
###begin title 28
Quantitative polymerase chain reaction analysis (qPCR)
###end title 28
###begin p 29
###xml 474 481 474 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 545 550 545 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
###xml 646 653 646 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
Total RNA was isolated from cultured cells using the RNeasy kit (Qiagen) and reverse transcription with random hexanucleotide primers and SuperScript Reverse Transcriptase III (Invitrogen) was performed. The resulting cDNA was amplified by real-time polymerase chain reaction using the iQ5 Real-Time PCR Detection System (BioRad) and Power SYBR Green PCR Master Mix (Applied Biosystems). Primer sequences were 5'-GTCGCCTGTCCACTTAGCC-3' and 5'-GCTGTTTGCCCGTTCTTATTACA-3' for ANKRD37, 5'-AGGCCAGCACATAGGAGAGA-3' and 5'-TTTCTTGCGCTTTCGTTTTT-3' for VEGFA and 5'-CGGCTACCACATCCAAGGAA-3' and 5'-GCTGGAATTACCGCGGCT-3' for 18S rRNA. Transcript levels of ANKRD37 were normalized to 18S rRNA.
###end p 29
###begin title 30
Western blotting
###end title 30
###begin p 31
###xml 86 87 86 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 179 180 176 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 182 183 179 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 488 493 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF1A</italic>
Cells were lysed in chilled lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM beta-glycerophosphate, 1 mM Na3VO4, 1 mM leupeptin) supplemented with the Complete protease inhibitor cocktail (Roche). Total 50 microg of protein extracts were resolved on a 3-8% NuPAGE Tris-acetate SDS polyacrylamide gel (Invitrogen) and transferred onto a polyvinylidene difluoride membrane (Millipore). The blots were probed with anti-HIF1A (Transduction Laboratories; 1:500) and anti-beta actin (Sigma; 1:100 000) antibodies. Immunoreactive proteins were visualized using the Western Lighting Chemiluminescence Reagent Plus (PerkinElmer Life Sciences).
###end p 31
###begin title 32
Plasmid constructions
###end title 32
###begin p 33
###xml 169 176 169 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 837 844 833 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 163 168 <span type="species:ncbi:9606">human</span>
###xml 254 259 <span type="species:ncbi:9606">human</span>
Fragments from -325 bp to +230 bp (promoter 1) -166 bp to +230 bp (promoter 2) or -78 bp to +230 bp (promoter 3) relative to the transcriptional start site of the human ANKRD37 promoter were amplified by polymerase chain reaction (PCR) using 1 microg of human genomic DNA extracted from DLD-1 cells. The PCR primers were as follows: -325 bp sense primer; 5'-AACCAAACGCGTCCAGTTTCCTGGTTACGTG-3', -166 bp sense primer; 5'-AACCAAACGCGTTCTCACGCCCACTGACTTA-3', -78 bp sense primer; 5'-AACCAAACGCGTATCCACAGCTGGCCAATCG-3' and +230 bp antisense primer; 5'-GTGGTTGAGATCTTAAGGCAGATGACAAGAGTCC-3'. The PCR-amplified products were digested with MluI and BglII and subcloned into the pGL3-basic vector (Promega). Site directed mutations were introduced at three potential HIF-binding sites (1, 2 and 4). To prepare site 1 and site 4 mutants, the -325 ANKRD37-luc pGL3 plasmid was digested with MluI/PstI or PmlI/Tth111I, respectively, and ligated with a double-stranded oligonucleotide in which the consensus HIF-binding site was disrupted. The oligonucleotide sequences were as follows: 5'-CGCGTCCAGTTTCCTGGTTAAAAGCGCGCCGGCAGAGCCAAAACCTGCA-3' and 5'-GGTTTTGGCTCTGCCGGCGCGCTTTTAACCAGGAAACTGGA-3' for site 1 at -310 bp and 5'-GTGCCAGTGTTTGTGTAAAAGCGGCCGTGGCGGGGCTGGACA-3' and 5'-CTGTCCAGCCCCGCCACGGCCGCTTTTACACAAACACTGGCAC-3' for site 4 at +14 bp. To prepare the site 2 mutant, PCR-based site-directed mutagenesis was performed using primers 5'-TACCGGGAGAAAAGTCAAACTCA-3' and 5'-TGAGTTTGACTTTTCTCCCGGTA-3'. The nucleotide sequences of all constructs were confirmed by sequencing.
###end p 33
###begin title 34
Transfections and reporter assays
###end title 34
###begin p 35
###xml 159 166 159 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 240 243 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Transient transfections were performed using Fugene 6 (Roche) in 24-well tissue culture plates according to the manufacturer's specifications. Total 150 ng of ANKRD37-luciferase pGL3 reporter constructs were co-transfected with 2 ng of pRL-CMV (Promega) as a control. Ten hours after transfection, the culture medium was switched to UltraCulture and cells were grown in normoxic or hypoxic conditions for 18 h. Luciferase activity was measured with a dual luciferase reporter assay system (Promega). The experiments were performed in triplicate wells a minimum of three times.
###end p 35
###begin title 36
RNA interference
###end title 36
###begin p 37
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF1A</italic>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF1A</italic>
###xml 416 423 416 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
HCT116 cells were transfected with 20 nM siRNA duplex oligos directed to HIF1A or a non-specific control siRNA using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer's instructions. Nucleotide sequences of siRNAs were as follows: HIF1A, 5'-r(AUCCAGAGUCACUGGAACU)d(TT)-3', and control, 5'-r(GCGCGCUUUGUAGGAUUCG)d(TT)-3'. The silencing effect was confirmed by Western blotting 48 h after transfection. ANKRD37 promoter reporter constructs were transfected 12 h after siRNA transfection.
###end p 37
###begin title 38
Electrophoretic mobility shift assay (EMSA)
###end title 38
###begin p 39
###xml 164 171 164 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
Nuclear extracts were prepared from MCF7 cells cultured in either normoxic or hypoxic conditions for 12 h utilizing NE-PER nuclear extraction reagent (Pierce). The ANKRD37 promoter sequence utilized as an oligonucleotide probe was 5'-CTACCGGGAGACGTGTCAAACTCAG-3'. The 5'-end of the oligonucleotide was labeled with biotin, and a complementary oligonucleotide was annealed to generate double-stranded fragments. EMSA was performed using LightShift chemiluminescent kit (Pierce) as previously described (54). Specificity of shifts was confirmed by utilizing 200-fold molar excess of unbiotinylated oligonucleotides as a specific competitor. Mutagenesis was performed to further define the elements responsible for the specific shifts obtained. The sequence of the mutant oligonucleotide probe that includes point mutations in the HIF consensus-binding site was: 5'-CTACCGGGAGAAAAGTCAAACTCAG-3'.
###end p 39
###begin title 40
Chromatin immunoprecipitation (ChIP)
###end title 40
###begin p 41
###xml 594 599 <span type="species:ncbi:10090">mouse</span>
MCF7 cells were cultured in either normoxic or hypoxic conditions for 6 h and then fixed with 1% formaldehyde at 37degreesC for 10 min. The ChIP assays were performed using a Chromatin Immunoprecipitation Assay Kit (Upstate) according to the manufacturer's protocol. Briefly, cells were lysed and sonicated to achieve DNA sizes ranging from 200 to 1000 bp. Diluted supernatants were pre-cleared by incubating with salmon sperm DNA/protein-A agarose, 50% slurry at 4degreesC for 30 min. Supernatants were then incubated with anti-HIF-1alpha antibody (Novus Biologicals number 100-105) or normal mouse IgG (Santa Cruz) at 4degreesC overnight, or directly processed to the next step without antibody. Immunocomplexes were collected with salmon sperm DNA/protein A-agarose, 50% slurry, washed, eluted and cross-linkage was reversed by heating at 65degreesC for 4 h. The eluates were then digested with proteinase K at 45degreesC for 1 h. The precipitated DNAs were recovered using PCR Purification Kit (Qiagen) and amplified by PCR using PrimeSTAR HS DNA Polymerase (Takara Bio). The PCR primers used for amplification of site 2 (primers A) and a non-HIF region upstream of site 2 (primers B) were as follows: sense primer A; 5'-CCAGTTTCCTGGTTACGTGC-3', anti-sense primer A; 5'-TAAGTCAGTGGGCGTGAGAG-3', sense primer B; 5'-TGGAGGCACTTTCACCACAC-3' and anti-sense primer B; 5'-TGTGAGGTGAGCACACGTTG-3'.
###end p 41
###begin title 42
RESULTS
###end title 42
###begin p 43
###xml 932 941 932 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-silico</italic>
HIF-1 and HIF-2 and their downstream-target genes are activated in response to hypoxia. To identify HIF-target genes we first identified genes that responded to hypoxia using publicly available microarray data sets. NCBI GEO and EBI ArrayExpress were searched for experiments where the same tissue was profiled comparing normoxia and hypoxia. Experiments that used replicates, were profiled on Affymetrix platform and provided raw data were accepted for further analysis (). The same identical analysis protocol was applied to all experiments (see 'Materials and Methods' section). Although all microarrays were profiled on Affymetrix arrays, the number of genes differentially expressed in each cell type varied significantly and ranged from 486 genes in monocytes to 2119 genes in HeLa, with a surprisingly small overlap. The differentially expressed genes in each cell type are the potential HIF-target genes and were subject to in-silico analysis of HIF-binding sites.
###end p 43
###begin title 44
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In-silico</italic>
In-silico optimization of HIF-binding site prediction
###end title 44
###begin p 45
###xml 428 433 428 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 387 392 <span type="species:ncbi:9606">human</span>
###xml 394 399 <span type="species:ncbi:10090">mouse</span>
###xml 404 407 <span type="species:ncbi:10116">rat</span>
Two databases of PWMs were obtained and searched for HIF-1 PWM. The Jaspar collection (v3.0) contained no HIF-1 PWM while the TRANSFAC collection (v8.2) contained 2 HIF-1 PWMs (M00466, M00797). These PWMs are 12 and 14 bases long and were compiled based on only 12 and 23 validated binding sites, respectively. We compiled an additional HIF-1 PWM based on 104 validated binding sites in human, mouse and rat collected by Wenger et al. (10) (see ; submitted to Jaspar). Despite the apparent variability in PWM length, it is clear from the alignment in  that most of the information content is within the HIF consensus binding site: RCGTG. The composition preference in the region flanking the core RCGTG observed in the Transfac matrices is a consequence of using a small number of validated HIF-1-binding sites.
###end p 45
###begin p 46
###xml 281 282 281 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 505 506 505 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1191 1192 1191 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1601 1605 1601 1605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNT</italic>
###xml 1633 1636 1630 1633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AHR</italic>
###xml 1637 1641 1634 1638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNT</italic>
###xml 1643 1646 1640 1643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1648 1651 1645 1648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAX</italic>
###xml 1653 1657 1650 1654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 1659 1664 1656 1661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLOCK</italic>
###xml 1665 1670 1662 1667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNTL</italic>
###xml 1675 1679 1672 1676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">USF1</italic>
###xml 2311 2316 2308 2313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BNIP3</italic>
###xml 2740 2748 2737 2745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 2965 2974 2962 2971 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 2974 3395 2971 3392 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="47">Prediction strategy for identifying HIF-1-target genes. Candidate genes that respond to hypoxia were first identified by microarrays. Each data set was subjected to a computational analysis in which HIF-binding sites were detected in proximal promoters. Each gene was scored for its response to hypoxia and for the best HIF-binding site. No cutoff was set for determining HIF-target genes. Finally, all genes were ranked.</p>
###xml 2974 3395 2971 3392 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="47">Prediction strategy for identifying HIF-1-target genes. Candidate genes that respond to hypoxia were first identified by microarrays. Each data set was subjected to a computational analysis in which HIF-binding sites were detected in proximal promoters. Each gene was scored for its response to hypoxia and for the best HIF-binding site. No cutoff was set for determining HIF-target genes. Finally, all genes were ranked.</p></caption>
###xml 3395 3395 3392 3392 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp425f1"/>
###xml 2965 3395 2962 3392 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="47">Prediction strategy for identifying HIF-1-target genes. Candidate genes that respond to hypoxia were first identified by microarrays. Each data set was subjected to a computational analysis in which HIF-binding sites were detected in proximal promoters. Each gene was scored for its response to hypoxia and for the best HIF-binding site. No cutoff was set for determining HIF-target genes. Finally, all genes were ranked.</p></caption><graphic xlink:href="gkp425f1"/></fig>
###xml 1135 1140 <span type="species:ncbi:9606">human</span>
Proximal promoters were defined from 700 bases upstream to 300 bases downstream of the transcription start site (TSS) of each transcript. Initially, HIF-1 PWMs were used to identify binding sites; however, we observed a too small overlap between the three HIF-1 PWMs for any given P-value and conservation filtering criteria. Differences in PWM length (12-18 bp) and in the sequences flanking the consensus binding site were found to introduce a bias in HIF-1-binding-site prediction since calculation of P-values and conservation consider the entire length of the matrix and all bases defined within. To avoid this bias all HIF consensus-binding sites sequences (RCGTG) were extracted from each promoter and tested for conservation in other species (see 'Materials and Methods' section). A shift from A to G and vice versa in the first position was allowed for the purpose of conservation. Next, the software site-cons in CREAD was employed to calculate the level of conservation at each binding site compared to the flanking 100 bases. A site was predicted as a HIF-binding site if it was conserved in at least 10 species (including human) or if conserved in four species with a site-cons P < 0.05. When the HIF consensus site is preceded by a C, it may form the E-box-binding site CACGTG which is a known binding site for several bHLH transcription factors including HIF-1. In 43% of the E-box sites other TFs were predicted to bind at the same location as HIF-1, compared to only 2% of the non-Ebox sites. The transcription factors that are most commonly predicted at the same location as HIF are ARNT (HIF-1beta; as homodimer), AHR:ARNT, MYC, MAX, MYCN, CLOCK:ARNTL and USF1 (). We only accepted genes with at least one non-Ebox HIF site as HIF-target genes. Throughout this strategy our filtering criteria were very stringent in order to obtain a catalogue of high confidence at the expense of not recovering some known HIF targets. Each gene was scored as follows:  The hypoxia/normoxia ratio was inverted and assigned a negative value for genes that were downregulated in hypoxia. Each gene was assigned two ranks, one based on the highest scoring HIF site and one on the hypoxia score. Finally, the sum of both ranks was calculated and all genes were ranked based on that value. For instance, the gene BNIP3, a bona fide HIF-1 target, was ranked 515 by HIF site score and 15 by hypoxia score. Using the sum of ranks BNIP3 was ranked 56 among all genes. This scoring scheme is biased towards genes that respond to hypoxia in multiple cells. While some genes could be HIF targets in only one cell, we reason that a gene that responds to hypoxia in more than one cell is more likely to be a HIF target. This strategy is summarized in Figure 1. Despite the stringent selection criteria of this approach we were able to identify a HIF-binding site in 35/86 promoters of known target genes. A list of previously identified known HIF-1-target genes is shown in . Figure 1.Prediction strategy for identifying HIF-1-target genes. Candidate genes that respond to hypoxia were first identified by microarrays. Each data set was subjected to a computational analysis in which HIF-binding sites were detected in proximal promoters. Each gene was scored for its response to hypoxia and for the best HIF-binding site. No cutoff was set for determining HIF-target genes. Finally, all genes were ranked.
###end p 46
###begin p 47
Prediction strategy for identifying HIF-1-target genes. Candidate genes that respond to hypoxia were first identified by microarrays. Each data set was subjected to a computational analysis in which HIF-binding sites were detected in proximal promoters. Each gene was scored for its response to hypoxia and for the best HIF-binding site. No cutoff was set for determining HIF-target genes. Finally, all genes were ranked.
###end p 47
###begin title 48
The majority of hypoxia responsive genes lack a HIF-binding site
###end title 48
###begin p 49
###xml 233 240 233 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 364 371 364 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 1314 1322 1314 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1653 1661 1653 1661 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1.</label>
###xml 1661 1757 1661 1757 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="50">Transcriptional response to hypoxia across six different cell types as determined by microarrays</p>
###xml 1661 1757 1661 1757 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="50">Transcriptional response to hypoxia across six different cell types as determined by microarrays</p></caption>
###xml 1757 1757 1757 1757 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1757 1761 1757 1761 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MCF7</th>
###xml 1761 1765 1761 1765 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">U251</th>
###xml 1765 1775 1765 1775 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Astrocytes</th>
###xml 1775 1784 1775 1784 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Monocytes</th>
###xml 1784 1791 1784 1791 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">B cells</th>
###xml 1791 1795 1791 1795 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HeLA</th>
###xml 1757 1795 1757 1795 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">MCF7</th><th rowspan="1" colspan="1">U251</th><th rowspan="1" colspan="1">Astrocytes</th><th rowspan="1" colspan="1">Monocytes</th><th rowspan="1" colspan="1">B cells</th><th rowspan="1" colspan="1">HeLA</th></tr>
###xml 1757 1795 1757 1795 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">MCF7</th><th rowspan="1" colspan="1">U251</th><th rowspan="1" colspan="1">Astrocytes</th><th rowspan="1" colspan="1">Monocytes</th><th rowspan="1" colspan="1">B cells</th><th rowspan="1" colspan="1">HeLA</th></tr></thead>
###xml 1795 1824 1795 1824 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Genes that respond to hypoxia</td>
###xml 1824 1827 1824 1827 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">830</td>
###xml 1827 1831 1827 1831 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1702</td>
###xml 1831 1835 1831 1835 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1371</td>
###xml 1835 1838 1835 1838 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">486</td>
###xml 1838 1842 1838 1842 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1920</td>
###xml 1842 1846 1842 1846 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">2119</td>
###xml 1795 1846 1795 1846 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Genes that respond to hypoxia</td><td rowspan="1" colspan="1">830</td><td rowspan="1" colspan="1">1702</td><td rowspan="1" colspan="1">1371</td><td rowspan="1" colspan="1">486</td><td rowspan="1" colspan="1">1920</td><td rowspan="1" colspan="1">2119</td></tr>
###xml 1846 1918 1846 1918 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Genes that respond to hypoxia in which a HIF binding site was identified</td>
###xml 1918 1927 1918 1927 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">278 (33%)</td>
###xml 1927 1936 1927 1936 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">546 (32%)</td>
###xml 1936 1945 1936 1945 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">380 (28%)</td>
###xml 1945 1954 1945 1954 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">159 (33%)</td>
###xml 1954 1963 1954 1963 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">534 (28%)</td>
###xml 1963 1972 1963 1972 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">555 (26%)</td>
###xml 1846 1972 1846 1972 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Genes that respond to hypoxia in which a HIF binding site was identified</td><td rowspan="1" colspan="1">278 (33%)</td><td rowspan="1" colspan="1">546 (32%)</td><td rowspan="1" colspan="1">380 (28%)</td><td rowspan="1" colspan="1">159 (33%)</td><td rowspan="1" colspan="1">534 (28%)</td><td rowspan="1" colspan="1">555 (26%)</td></tr>
###xml 1972 2014 1972 2014 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Known target genes that respond to hypoxia</td>
###xml 2014 2016 2014 2016 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">35</td>
###xml 2016 2018 2016 2018 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">31</td>
###xml 2018 2020 2018 2020 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">20</td>
###xml 2020 2022 2020 2022 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">22</td>
###xml 2022 2024 2022 2024 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">32</td>
###xml 2024 2026 2024 2026 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">27</td>
###xml 1972 2026 1972 2026 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Known target genes that respond to hypoxia</td><td rowspan="1" colspan="1">35</td><td rowspan="1" colspan="1">31</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">27</td></tr>
###xml 2026 2053 2026 2053 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Known target genes recovery</td>
###xml 2053 2061 2053 2061 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">19 (54%)</td>
###xml 2061 2069 2061 2069 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">17 (55%)</td>
###xml 2069 2076 2069 2076 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">8 (40%)</td>
###xml 2076 2084 2076 2084 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">11 (50%)</td>
###xml 2084 2092 2084 2092 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">13 (41%)</td>
###xml 2092 2100 2092 2100 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">10 (37%)</td>
###xml 2026 2100 2026 2100 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Known target genes recovery</td><td rowspan="1" colspan="1">19 (54%)</td><td rowspan="1" colspan="1">17 (55%)</td><td rowspan="1" colspan="1">8 (40%)</td><td rowspan="1" colspan="1">11 (50%)</td><td rowspan="1" colspan="1">13 (41%)</td><td rowspan="1" colspan="1">10 (37%)</td></tr>
###xml 1795 2100 1795 2100 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">Genes that respond to hypoxia</td><td rowspan="1" colspan="1">830</td><td rowspan="1" colspan="1">1702</td><td rowspan="1" colspan="1">1371</td><td rowspan="1" colspan="1">486</td><td rowspan="1" colspan="1">1920</td><td rowspan="1" colspan="1">2119</td></tr><tr><td rowspan="1" colspan="1">Genes that respond to hypoxia in which a HIF binding site was identified</td><td rowspan="1" colspan="1">278 (33%)</td><td rowspan="1" colspan="1">546 (32%)</td><td rowspan="1" colspan="1">380 (28%)</td><td rowspan="1" colspan="1">159 (33%)</td><td rowspan="1" colspan="1">534 (28%)</td><td rowspan="1" colspan="1">555 (26%)</td></tr><tr><td rowspan="1" colspan="1">Known target genes that respond to hypoxia</td><td rowspan="1" colspan="1">35</td><td rowspan="1" colspan="1">31</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">27</td></tr><tr><td rowspan="1" colspan="1">Known target genes recovery</td><td rowspan="1" colspan="1">19 (54%)</td><td rowspan="1" colspan="1">17 (55%)</td><td rowspan="1" colspan="1">8 (40%)</td><td rowspan="1" colspan="1">11 (50%)</td><td rowspan="1" colspan="1">13 (41%)</td><td rowspan="1" colspan="1">10 (37%)</td></tr></tbody>
###xml 1757 2100 1757 2100 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">MCF7</th><th rowspan="1" colspan="1">U251</th><th rowspan="1" colspan="1">Astrocytes</th><th rowspan="1" colspan="1">Monocytes</th><th rowspan="1" colspan="1">B cells</th><th rowspan="1" colspan="1">HeLA</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Genes that respond to hypoxia</td><td rowspan="1" colspan="1">830</td><td rowspan="1" colspan="1">1702</td><td rowspan="1" colspan="1">1371</td><td rowspan="1" colspan="1">486</td><td rowspan="1" colspan="1">1920</td><td rowspan="1" colspan="1">2119</td></tr><tr><td rowspan="1" colspan="1">Genes that respond to hypoxia in which a HIF binding site was identified</td><td rowspan="1" colspan="1">278 (33%)</td><td rowspan="1" colspan="1">546 (32%)</td><td rowspan="1" colspan="1">380 (28%)</td><td rowspan="1" colspan="1">159 (33%)</td><td rowspan="1" colspan="1">534 (28%)</td><td rowspan="1" colspan="1">555 (26%)</td></tr><tr><td rowspan="1" colspan="1">Known target genes that respond to hypoxia</td><td rowspan="1" colspan="1">35</td><td rowspan="1" colspan="1">31</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">27</td></tr><tr><td rowspan="1" colspan="1">Known target genes recovery</td><td rowspan="1" colspan="1">19 (54%)</td><td rowspan="1" colspan="1">17 (55%)</td><td rowspan="1" colspan="1">8 (40%)</td><td rowspan="1" colspan="1">11 (50%)</td><td rowspan="1" colspan="1">13 (41%)</td><td rowspan="1" colspan="1">10 (37%)</td></tr></tbody></table>
###xml 1653 2100 1653 2100 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1.</label><caption><p textid="50">Transcriptional response to hypoxia across six different cell types as determined by microarrays</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">MCF7</th><th rowspan="1" colspan="1">U251</th><th rowspan="1" colspan="1">Astrocytes</th><th rowspan="1" colspan="1">Monocytes</th><th rowspan="1" colspan="1">B cells</th><th rowspan="1" colspan="1">HeLA</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Genes that respond to hypoxia</td><td rowspan="1" colspan="1">830</td><td rowspan="1" colspan="1">1702</td><td rowspan="1" colspan="1">1371</td><td rowspan="1" colspan="1">486</td><td rowspan="1" colspan="1">1920</td><td rowspan="1" colspan="1">2119</td></tr><tr><td rowspan="1" colspan="1">Genes that respond to hypoxia in which a HIF binding site was identified</td><td rowspan="1" colspan="1">278 (33%)</td><td rowspan="1" colspan="1">546 (32%)</td><td rowspan="1" colspan="1">380 (28%)</td><td rowspan="1" colspan="1">159 (33%)</td><td rowspan="1" colspan="1">534 (28%)</td><td rowspan="1" colspan="1">555 (26%)</td></tr><tr><td rowspan="1" colspan="1">Known target genes that respond to hypoxia</td><td rowspan="1" colspan="1">35</td><td rowspan="1" colspan="1">31</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">27</td></tr><tr><td rowspan="1" colspan="1">Known target genes recovery</td><td rowspan="1" colspan="1">19 (54%)</td><td rowspan="1" colspan="1">17 (55%)</td><td rowspan="1" colspan="1">8 (40%)</td><td rowspan="1" colspan="1">11 (50%)</td><td rowspan="1" colspan="1">13 (41%)</td><td rowspan="1" colspan="1">10 (37%)</td></tr></tbody></table></table-wrap>
###xml 2100 2109 2100 2109 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 2110 2111 2110 2111 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2116 2117 2116 2117 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2715 2716 2715 2716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2725 2726 2725 2726 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2109 3023 2109 3023 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="51">(<bold>A</bold> and <bold>B</bold>) Binding site enrichment analysis. The program MOTIFCLASS was employed to identify binding sites significantly over-represented in the promoters of genes that respond to hypoxia in B cells. (A) Totally 770 promoters of genes that responded to hypoxia in which a detectable HIF-1-binding site was identified. HIF-1 PWMs were identified as the most enriched. (B) Totally 1456 promoters of genes that responded to hypoxia but do not contain a detectable HIF-1-binding site. No HIF-1 PWM was identified in the top 20 matrices. Sn, sensitivity; Sp, specificity; Error, classification error rate; Pval, <italic>P</italic>-value. (<bold>C</bold>) Correlation between the number of HIF-target genes and the number of cells in which they responded to hypoxia. Only 31% of the genes that responded to hypoxia in one of six cells was predicted as a HIF-target gene, compared to 71% of the genes that responded to hypoxia in six of six cell lines.</p>
###xml 2109 3023 2109 3023 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="51">(<bold>A</bold> and <bold>B</bold>) Binding site enrichment analysis. The program MOTIFCLASS was employed to identify binding sites significantly over-represented in the promoters of genes that respond to hypoxia in B cells. (A) Totally 770 promoters of genes that responded to hypoxia in which a detectable HIF-1-binding site was identified. HIF-1 PWMs were identified as the most enriched. (B) Totally 1456 promoters of genes that responded to hypoxia but do not contain a detectable HIF-1-binding site. No HIF-1 PWM was identified in the top 20 matrices. Sn, sensitivity; Sp, specificity; Error, classification error rate; Pval, <italic>P</italic>-value. (<bold>C</bold>) Correlation between the number of HIF-target genes and the number of cells in which they responded to hypoxia. Only 31% of the genes that responded to hypoxia in one of six cells was predicted as a HIF-target gene, compared to 71% of the genes that responded to hypoxia in six of six cell lines.</p></caption>
###xml 3023 3023 3023 3023 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp425f2"/>
###xml 2100 3023 2100 3023 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="51">(<bold>A</bold> and <bold>B</bold>) Binding site enrichment analysis. The program MOTIFCLASS was employed to identify binding sites significantly over-represented in the promoters of genes that respond to hypoxia in B cells. (A) Totally 770 promoters of genes that responded to hypoxia in which a detectable HIF-1-binding site was identified. HIF-1 PWMs were identified as the most enriched. (B) Totally 1456 promoters of genes that responded to hypoxia but do not contain a detectable HIF-1-binding site. No HIF-1 PWM was identified in the top 20 matrices. Sn, sensitivity; Sp, specificity; Error, classification error rate; Pval, <italic>P</italic>-value. (<bold>C</bold>) Correlation between the number of HIF-target genes and the number of cells in which they responded to hypoxia. Only 31% of the genes that responded to hypoxia in one of six cells was predicted as a HIF-target gene, compared to 71% of the genes that responded to hypoxia in six of six cell lines.</p></caption><graphic xlink:href="gkp425f2"/></fig>
HIF-target genes were predicted for each data set separately with the criteria outlined in 'Materials and Methods' section. Of the known and validated HIF-target genes that responded to hypoxia in each data set, we recovered 37-55% (Table 1). On average 70% of the hypoxia responsive genes did not contain a detectable HIF-binding site in their proximal promoter (Table 1). To verify this observation and to test that no bias was introduced by our stringent conservation filtering above, genes that responded to hypoxia in each data set were divided to two groups. Those with a predicted HIF-binding site (A) and those with no detectable HIF-binding site (B). Each group was tested for over-representation of any PWM compared to a random set of promoters with similar base composition and CpG content. This analysis was performed using the program MOTIFCLASS in CREAD and is independent from the prediction analysis and selection criteria outlined above. In addition, MOTIFCLASS does not consider conservation and is based on sequence analysis alone. As expected HIF PWMs were identified in the top 20 over-represented binding sites in group A and none of the HIF PWMs were detected in the top 20 PWMs from group B. The results for the top 20 enriched motifs in each group in MCF7 breast cancer cells are shown in Figure 2A and B. The highest scoring PWM was a HIF-1 matrix that had a classification error of 0.407. In each of the six data sets we observed HIF-1 enrichment in group A while group B varied significantly between cell types (). We did not observe any significant HIF enrichment within the top 20 PWMs in group B throughout all data sets. Table 1.Transcriptional response to hypoxia across six different cell types as determined by microarraysMCF7U251AstrocytesMonocytesB cellsHeLAGenes that respond to hypoxia8301702137148619202119Genes that respond to hypoxia in which a HIF binding site was identified278 (33%)546 (32%)380 (28%)159 (33%)534 (28%)555 (26%)Known target genes that respond to hypoxia353120223227Known target genes recovery19 (54%)17 (55%)8 (40%)11 (50%)13 (41%)10 (37%)Figure 2.(A and B) Binding site enrichment analysis. The program MOTIFCLASS was employed to identify binding sites significantly over-represented in the promoters of genes that respond to hypoxia in B cells. (A) Totally 770 promoters of genes that responded to hypoxia in which a detectable HIF-1-binding site was identified. HIF-1 PWMs were identified as the most enriched. (B) Totally 1456 promoters of genes that responded to hypoxia but do not contain a detectable HIF-1-binding site. No HIF-1 PWM was identified in the top 20 matrices. Sn, sensitivity; Sp, specificity; Error, classification error rate; Pval, P-value. (C) Correlation between the number of HIF-target genes and the number of cells in which they responded to hypoxia. Only 31% of the genes that responded to hypoxia in one of six cells was predicted as a HIF-target gene, compared to 71% of the genes that responded to hypoxia in six of six cell lines.
###end p 49
###begin p 50
Transcriptional response to hypoxia across six different cell types as determined by microarrays
###end p 50
###begin p 51
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 7 8 7 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 606 607 606 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 616 617 616 617 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
(A and B) Binding site enrichment analysis. The program MOTIFCLASS was employed to identify binding sites significantly over-represented in the promoters of genes that respond to hypoxia in B cells. (A) Totally 770 promoters of genes that responded to hypoxia in which a detectable HIF-1-binding site was identified. HIF-1 PWMs were identified as the most enriched. (B) Totally 1456 promoters of genes that responded to hypoxia but do not contain a detectable HIF-1-binding site. No HIF-1 PWM was identified in the top 20 matrices. Sn, sensitivity; Sp, specificity; Error, classification error rate; Pval, P-value. (C) Correlation between the number of HIF-target genes and the number of cells in which they responded to hypoxia. Only 31% of the genes that responded to hypoxia in one of six cells was predicted as a HIF-target gene, compared to 71% of the genes that responded to hypoxia in six of six cell lines.
###end p 51
###begin title 52
The general response to hypoxia is dependent on a small number of genes
###end title 52
###begin p 53
###xml 82 87 82 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55 B56 B57">55&#8211;57</xref>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENO1</italic>
###xml 449 455 449 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BHLHB2</italic>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BNIP3</italic>
###xml 628 636 628 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 849 856 849 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMEM45A</italic>
###xml 1016 1017 1016 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1158 1163 1158 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDIT4</italic>
###xml 1165 1167 1165 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 1168 1170 1168 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 1173 1177 1173 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STC2</italic>
###xml 1179 1181 1179 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 1184 1189 1184 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P4HA1</italic>
###xml 1191 1193 1191 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B61">61</xref>
###xml 1196 1202 1196 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JMJD1A</italic>
###xml 1204 1206 1204 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B62">62</xref>
###xml 1212 1217 1212 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALDOC</italic>
###xml 1219 1221 1219 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B63">63</xref>
Previous studies have suggested that the response to hypoxia varies by cell type (55-57). However, we expected a core set of genes to be shared, e.g. genes that control the shift from oxidative to glycolytic metabolism and inhibition of cellular proliferation. Yet, the cellular response to hypoxia was surprisingly selective between cells. Only 17 genes responded to hypoxia in all studied cell types. These genes include HIF targets such as ENO1, BHLHB2 and BNIP3. We observed a positive correlation between the number of cells in which a gene responded to hypoxia and the identification of HIF-binding sites in its promoter (Figure 2C). Only 23% of the genes that responded to hypoxia in a single cell type had a predicted HIF-binding site in their promoter compared to 59% of the genes that responded in six cell types. The top scoring gene was TMEM45A which responded to hypoxia in all studied cell types with an average of 21.6-fold induction and a HIF-binding site conserved in 13 species with a conservation P-value <0.0001 compared to the flanking 100 bp. At least 5 of the top 10 genes have been previously identified as HIF-1-target genes, namely DDIT4 (58,59), STC2 (60), P4HA1 (61), JMJD1A (62) and ALDOC (63). We did not find any correlation between the response to hypoxia and the HIF-binding site score for the top 100 predicted HIF-target genes. To obtain a cutoff of high confidence, the top 500 ranked genes were plotted versus the cumulative number of previously validated HIF-1 targets (). The resulting curve showed a logarithmic increase in validated targets for genes ranking below 200 and approached saturation between 200 and 500. Therefore, the 200th gene rank was used as a cutoff of high confidence.  summarizes our prediction results for the top 500 HIF-target genes.
###end p 53
###begin p 54
###xml 97 105 97 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 922 930 922 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1088 1092 1088 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LDHA</italic>
###xml 1094 1099 1094 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALDOC</italic>
###xml 1104 1109 1104 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 1149 1153 1149 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GYS1</italic>
###xml 1188 1190 1188 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 1216 1218 1216 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FH</italic>
###xml 1238 1240 1238 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 1615 1623 1615 1623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1785 1786 1785 1786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 1809 1817 1809 1817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC25A28</italic>
###xml 1866 1870 1866 1870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ISCU</italic>
###xml 1872 1881 1872 1881 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 1881 2220 1881 2220 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="55">HIF dependent response to hypoxia across six cell types for 81 selected genes that respond to hypoxia in at least three cell types and were ranked within the top 200 HIF-target genes. The heatmap shows a fold induction compared to normoxia within each cell type. White blocks indicate the gene did not respond to hypoxia in that cell type.</p>
###xml 1881 2220 1881 2220 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="55">HIF dependent response to hypoxia across six cell types for 81 selected genes that respond to hypoxia in at least three cell types and were ranked within the top 200 HIF-target genes. The heatmap shows a fold induction compared to normoxia within each cell type. White blocks indicate the gene did not respond to hypoxia in that cell type.</p></caption>
###xml 2220 2220 2220 2220 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp425f3"/>
###xml 1872 2220 1872 2220 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="55">HIF dependent response to hypoxia across six cell types for 81 selected genes that respond to hypoxia in at least three cell types and were ranked within the top 200 HIF-target genes. The heatmap shows a fold induction compared to normoxia within each cell type. White blocks indicate the gene did not respond to hypoxia in that cell type.</p></caption><graphic xlink:href="gkp425f3"/></fig>
###xml 2220 2229 2220 2229 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 2230 2231 2230 2231 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2481 2482 2481 2482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2686 2687 2686 2687 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 3165 3166 3165 3166 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 3255 3256 3255 3256 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 3409 3410 3409 3410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2229 3434 2229 3434 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="56">(<bold>A</bold>) Metabolic map of HIF-target genes. The KEGG pathway database was employed to map 81 HIF-target genes defined as the core response to hypoxia to pathways. Metabolism related processes are shown here (black objects) and those over-represented with a <italic>P</italic> &lt; 0.05 are shown with a dotted white frame. Upregulated genes are shown as red nodes while downregulated genes as green nodes. Previously identified HIF-1-target genes are indicated by a diamond shape. (<bold>B</bold>) Mitochondrial map. Genes within the top 200 predicted HIF targets that localize to the mitochondria were mapped according to their functional annotation. Upregulated genes are shown as red nodes and downregulated as green nodes. Genes indicated in bold responded to hypoxia in at least three cell types. Dotted lines from iron&#8211;sulfur protein assembly and repair illustrate a few of the iron&#8211;sulfur proteins that are key to mitochondrial function, such as NADH dehydrogenase. (<bold>C</bold>) Graphical representation of protein-protein interaction network and Reactome pathways (<bold>D</bold>) enrichment for previously validated HIF-1 targets (red) and novel predicted targets (yellow). Only proteins/pathways that were significantly enriched (<italic>P</italic> &lt; 0.05) are shown. See <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkp425/DC1">Supplementary Table S6</ext-link> for analysis details.</p>
###xml 2229 3456 2229 3456 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="56">(<bold>A</bold>) Metabolic map of HIF-target genes. The KEGG pathway database was employed to map 81 HIF-target genes defined as the core response to hypoxia to pathways. Metabolism related processes are shown here (black objects) and those over-represented with a <italic>P</italic> &lt; 0.05 are shown with a dotted white frame. Upregulated genes are shown as red nodes while downregulated genes as green nodes. Previously identified HIF-1-target genes are indicated by a diamond shape. (<bold>B</bold>) Mitochondrial map. Genes within the top 200 predicted HIF targets that localize to the mitochondria were mapped according to their functional annotation. Upregulated genes are shown as red nodes and downregulated as green nodes. Genes indicated in bold responded to hypoxia in at least three cell types. Dotted lines from iron&#8211;sulfur protein assembly and repair illustrate a few of the iron&#8211;sulfur proteins that are key to mitochondrial function, such as NADH dehydrogenase. (<bold>C</bold>) Graphical representation of protein-protein interaction network and Reactome pathways (<bold>D</bold>) enrichment for previously validated HIF-1 targets (red) and novel predicted targets (yellow). Only proteins/pathways that were significantly enriched (<italic>P</italic> &lt; 0.05) are shown. See <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkp425/DC1">Supplementary Table S6</ext-link> for analysis details.</p></caption>
###xml 3456 3456 3456 3456 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp425f4"/>
###xml 2220 3456 2220 3456 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="56">(<bold>A</bold>) Metabolic map of HIF-target genes. The KEGG pathway database was employed to map 81 HIF-target genes defined as the core response to hypoxia to pathways. Metabolism related processes are shown here (black objects) and those over-represented with a <italic>P</italic> &lt; 0.05 are shown with a dotted white frame. Upregulated genes are shown as red nodes while downregulated genes as green nodes. Previously identified HIF-1-target genes are indicated by a diamond shape. (<bold>B</bold>) Mitochondrial map. Genes within the top 200 predicted HIF targets that localize to the mitochondria were mapped according to their functional annotation. Upregulated genes are shown as red nodes and downregulated as green nodes. Genes indicated in bold responded to hypoxia in at least three cell types. Dotted lines from iron&#8211;sulfur protein assembly and repair illustrate a few of the iron&#8211;sulfur proteins that are key to mitochondrial function, such as NADH dehydrogenase. (<bold>C</bold>) Graphical representation of protein-protein interaction network and Reactome pathways (<bold>D</bold>) enrichment for previously validated HIF-1 targets (red) and novel predicted targets (yellow). Only proteins/pathways that were significantly enriched (<italic>P</italic> &lt; 0.05) are shown. See <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkp425/DC1">Supplementary Table S6</ext-link> for analysis details.</p></caption><graphic xlink:href="gkp425f4"/></fig>
In the top 200 predicted HIF-target genes, 81 responded to hypoxia in at least three cell types (Figure 3). We hypothesize that these genes are likely to be part of the core response to hypoxia. In addition, these genes have a higher probability of being HIF-1 targets since their response to hypoxia was detected in multiple experiments. Of the 81 genes, 22 genes were previously reported to be HIF-target genes and 60 genes (74%) were upregulated in hypoxia. In addition, 80 (99%) of the genes contained a CpG island in their proximal promoter, significantly higher than the 51% CpG containing promoters in our entire promoter database. CpG islands are thought to be non-tissue specific (64), further supporting the selection of the 81 genes as a shared response to hypoxia. The Kyoto Encyclopedia of Genes and Genomes (KEGG) database was used to identify over-represented pathways and processes within the 81 genes. In Figure 4A a metabolic map of HIF-1-target genes was constructed from the resulting analysis (). The metabolic map contained several known HIF-1-target genes, such as LDHA, ALDOC and GAPDH and also several novel targets such as GYS1 in starch and sucrose metabolism (65) and fumarate hydratase (FH) in the TCA cycle (66). One of the key cellular responses to HIF-1 in hypoxia is a metabolic shift from oxidative phosphorylation to glycolytic production of ATP. To highlight direct targets that may be involved in HIF-1 regulation of mitochondria function the predicted HIF targets that localize to the mitochondria (see 'Materials and Methods' section) were used to create a mitochondrial map (Figure 4B). Eight of eleven genes were downregulated in hypoxia and are involved in critical steps of mitochondrial function including two ribosomal subunits, cytochrome c, the iron transporter SLC25A28 and the iron-sulfur assembly and repair protein ISCU. Figure 3.HIF dependent response to hypoxia across six cell types for 81 selected genes that respond to hypoxia in at least three cell types and were ranked within the top 200 HIF-target genes. The heatmap shows a fold induction compared to normoxia within each cell type. White blocks indicate the gene did not respond to hypoxia in that cell type.Figure 4.(A) Metabolic map of HIF-target genes. The KEGG pathway database was employed to map 81 HIF-target genes defined as the core response to hypoxia to pathways. Metabolism related processes are shown here (black objects) and those over-represented with a P < 0.05 are shown with a dotted white frame. Upregulated genes are shown as red nodes while downregulated genes as green nodes. Previously identified HIF-1-target genes are indicated by a diamond shape. (B) Mitochondrial map. Genes within the top 200 predicted HIF targets that localize to the mitochondria were mapped according to their functional annotation. Upregulated genes are shown as red nodes and downregulated as green nodes. Genes indicated in bold responded to hypoxia in at least three cell types. Dotted lines from iron-sulfur protein assembly and repair illustrate a few of the iron-sulfur proteins that are key to mitochondrial function, such as NADH dehydrogenase. (C) Graphical representation of protein-protein interaction network and Reactome pathways (D) enrichment for previously validated HIF-1 targets (red) and novel predicted targets (yellow). Only proteins/pathways that were significantly enriched (P < 0.05) are shown. See  for analysis details.
###end p 54
###begin p 55
HIF dependent response to hypoxia across six cell types for 81 selected genes that respond to hypoxia in at least three cell types and were ranked within the top 200 HIF-target genes. The heatmap shows a fold induction compared to normoxia within each cell type. White blocks indicate the gene did not respond to hypoxia in that cell type.
###end p 55
###begin p 56
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 252 253 252 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 457 458 457 458 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 936 937 936 937 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1026 1027 1026 1027 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1180 1181 1180 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(A) Metabolic map of HIF-target genes. The KEGG pathway database was employed to map 81 HIF-target genes defined as the core response to hypoxia to pathways. Metabolism related processes are shown here (black objects) and those over-represented with a P < 0.05 are shown with a dotted white frame. Upregulated genes are shown as red nodes while downregulated genes as green nodes. Previously identified HIF-1-target genes are indicated by a diamond shape. (B) Mitochondrial map. Genes within the top 200 predicted HIF targets that localize to the mitochondria were mapped according to their functional annotation. Upregulated genes are shown as red nodes and downregulated as green nodes. Genes indicated in bold responded to hypoxia in at least three cell types. Dotted lines from iron-sulfur protein assembly and repair illustrate a few of the iron-sulfur proteins that are key to mitochondrial function, such as NADH dehydrogenase. (C) Graphical representation of protein-protein interaction network and Reactome pathways (D) enrichment for previously validated HIF-1 targets (red) and novel predicted targets (yellow). Only proteins/pathways that were significantly enriched (P < 0.05) are shown. See  for analysis details.
###end p 56
###begin title 57
Classification of novel HIF targets
###end title 57
###begin p 58
###xml 583 590 583 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 773 774 773 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 778 779 778 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</italic>
###xml 1354 1355 1350 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1359 1360 1355 1356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</italic>
###xml 1474 1482 1470 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1599 1607 1595 1603 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2.</label>
###xml 1607 1740 1603 1736 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="59">Selected examples of functional enrichment of 101 previously validated HIF-1 targets and mapping of novel targets to these categories</p>
###xml 1607 1740 1603 1736 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="59">Selected examples of functional enrichment of 101 previously validated HIF-1 targets and mapping of novel targets to these categories</p></caption>
###xml 1740 1746 1736 1742 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Source</th>
###xml 1746 1757 1742 1753 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Description</th>
###xml 1757 1772 1753 1768 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Number of genes</th>
###xml 1806 1806 1802 1802 <hr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 1772 1806 1768 1802 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" colspan="2" rowspan="1">Previously validated HIF-1 targets<hr/></th>
###xml 1806 1825 1802 1821 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Novel HIF-1 targets</th>
###xml 1740 1825 1736 1821 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Source</th><th rowspan="1" colspan="1">Description</th><th rowspan="1" colspan="1">Number of genes</th><th colspan="2" rowspan="1">Previously validated HIF-1 targets<hr/></th><th rowspan="1" colspan="1">Novel HIF-1 targets</th></tr>
###xml 1825 1825 1821 1821 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1825 1825 1821 1821 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1825 1825 1821 1821 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1825 1826 1821 1822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1825 1832 1821 1828 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>P</italic>-value</th>
###xml 1832 1844 1828 1840 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Gene symbols</th>
###xml 1825 1844 1821 1840 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"><italic>P</italic>-value</th><th rowspan="1" colspan="1">Gene symbols</th></tr>
###xml 1740 1844 1736 1840 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Source</th><th rowspan="1" colspan="1">Description</th><th rowspan="1" colspan="1">Number of genes</th><th colspan="2" rowspan="1">Previously validated HIF-1 targets<hr/></th><th rowspan="1" colspan="1">Novel HIF-1 targets</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"><italic>P</italic>-value</th><th rowspan="1" colspan="1">Gene symbols</th></tr></thead>
###xml 1844 1859 1840 1855 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Protein domains</td>
###xml 1859 1921 1855 1917 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">IPR005123; 2-oxoglutarate (2OG) and Fe(II)-dependent oxogenase</td>
###xml 1921 1925 1917 1921 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">6/19</td>
###xml 1925 1931 1921 1927 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">2.E-07</td>
###xml 1931 1963 1927 1959 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">P4HA2, EGLN3, EGLN1, P4HA1, PH-4</td>
###xml 1963 1968 1959 1964 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PLOD1</td>
###xml 1844 1968 1840 1964 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Protein domains</td><td rowspan="1" colspan="1">IPR005123; 2-oxoglutarate (2OG) and Fe(II)-dependent oxogenase</td><td rowspan="1" colspan="1">6/19</td><td rowspan="1" colspan="1">2.E-07</td><td rowspan="1" colspan="1">P4HA2, EGLN3, EGLN1, P4HA1, PH-4</td><td rowspan="1" colspan="1">PLOD1</td></tr>
###xml 1968 1972 1964 1968 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GSEA</td>
###xml 1972 2017 1968 2013 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Poor progonosis marker genes in Breast Cancer</td>
###xml 2017 2023 2013 2019 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">13/104</td>
###xml 2023 2029 2019 2025 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.E-07</td>
###xml 2029 2081 2025 2077 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CA9, CP, PGK1, EGLN1, TFRC, VEGFA, NDRG1, ADM, BNIP3</td>
###xml 2081 2113 2077 2109 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">TMEFF1, IVNS1ABP, TMEM45A, RRAGD</td>
###xml 1968 2113 1964 2109 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">GSEA</td><td rowspan="1" colspan="1">Poor progonosis marker genes in Breast Cancer</td><td rowspan="1" colspan="1">13/104</td><td rowspan="1" colspan="1">1.E-07</td><td rowspan="1" colspan="1">CA9, CP, PGK1, EGLN1, TFRC, VEGFA, NDRG1, ADM, BNIP3</td><td rowspan="1" colspan="1">TMEFF1, IVNS1ABP, TMEM45A, RRAGD</td></tr>
###xml 2113 2117 2109 2113 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">KEGG</td>
###xml 2117 2148 2113 2144 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Arginine and proline metabolism</td>
###xml 2148 2152 2144 2148 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">6/35</td>
###xml 2152 2158 2148 2154 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">4.E-05</td>
###xml 2158 2183 2154 2179 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">P4HA2, NOS3, P4HA1, NOS2A</td>
###xml 2183 2196 2179 2192 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">EPRS, ALDH4A1</td>
###xml 2113 2196 2109 2192 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">KEGG</td><td rowspan="1" colspan="1">Arginine and proline metabolism</td><td rowspan="1" colspan="1">6/35</td><td rowspan="1" colspan="1">4.E-05</td><td rowspan="1" colspan="1">P4HA2, NOS3, P4HA1, NOS2A</td><td rowspan="1" colspan="1">EPRS, ALDH4A1</td></tr>
###xml 2196 2204 2192 2200 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Reactome</td>
###xml 2204 2223 2200 2219 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Platelet activation</td>
###xml 2223 2227 2219 2223 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">7/86</td>
###xml 2227 2233 2223 2229 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.E-02</td>
###xml 2233 2274 2229 2270 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PDGFA, TGFB3, FN1, VEGFA, ALDOA, SERPINE1</td>
###xml 2274 2281 2270 2277 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ARHGEF1</td>
###xml 2196 2281 2192 2277 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Reactome</td><td rowspan="1" colspan="1">Platelet activation</td><td rowspan="1" colspan="1">7/86</td><td rowspan="1" colspan="1">1.E-02</td><td rowspan="1" colspan="1">PDGFA, TGFB3, FN1, VEGFA, ALDOA, SERPINE1</td><td rowspan="1" colspan="1">ARHGEF1</td></tr>
###xml 2281 2291 2277 2287 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">TargetScan</td>
###xml 2291 2300 2287 2296 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MiR-1/206</td>
###xml 2300 2306 2296 2302 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">23/583</td>
###xml 2306 2312 2302 2308 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">3.E-03</td>
###xml 2312 2371 2308 2367 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PDGFA, NAMPT, HSP90B1, MET, ETS1, VEGFA, EDN1, CITED2, STC2</td>
###xml 2371 2468 2367 2464 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">RNF165, GRK6, SLC7A6, PTPLAD1, ASPH, MYLK, RSBN1, SLC31A1, EVI1, PGAM1, SOX6, BTAF1, MXD1, GLCCI1</td>
###xml 2281 2468 2277 2464 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">TargetScan</td><td rowspan="1" colspan="1">MiR-1/206</td><td rowspan="1" colspan="1">23/583</td><td rowspan="1" colspan="1">3.E-03</td><td rowspan="1" colspan="1">PDGFA, NAMPT, HSP90B1, MET, ETS1, VEGFA, EDN1, CITED2, STC2</td><td rowspan="1" colspan="1">RNF165, GRK6, SLC7A6, PTPLAD1, ASPH, MYLK, RSBN1, SLC31A1, EVI1, PGAM1, SOX6, BTAF1, MXD1, GLCCI1</td></tr>
###xml 2468 2488 2464 2484 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Protein interactions</td>
###xml 2488 2492 2484 2488 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PCAF</td>
###xml 2492 2498 2488 2494 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">10/106</td>
###xml 2498 2504 2494 2500 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">9.E-05</td>
###xml 2504 2527 2500 2523 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ENO1, NR4A1, PFKL, PGK1</td>
###xml 2527 2564 2523 2560 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">RARA, CCNB1, SSRP1, RBPJ, EVI1, BTAF1</td>
###xml 2468 2564 2464 2560 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Protein interactions</td><td rowspan="1" colspan="1">PCAF</td><td rowspan="1" colspan="1">10/106</td><td rowspan="1" colspan="1">9.E-05</td><td rowspan="1" colspan="1">ENO1, NR4A1, PFKL, PGK1</td><td rowspan="1" colspan="1">RARA, CCNB1, SSRP1, RBPJ, EVI1, BTAF1</td></tr>
###xml 1844 2564 1840 2560 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">Protein domains</td><td rowspan="1" colspan="1">IPR005123; 2-oxoglutarate (2OG) and Fe(II)-dependent oxogenase</td><td rowspan="1" colspan="1">6/19</td><td rowspan="1" colspan="1">2.E-07</td><td rowspan="1" colspan="1">P4HA2, EGLN3, EGLN1, P4HA1, PH-4</td><td rowspan="1" colspan="1">PLOD1</td></tr><tr><td rowspan="1" colspan="1">GSEA</td><td rowspan="1" colspan="1">Poor progonosis marker genes in Breast Cancer</td><td rowspan="1" colspan="1">13/104</td><td rowspan="1" colspan="1">1.E-07</td><td rowspan="1" colspan="1">CA9, CP, PGK1, EGLN1, TFRC, VEGFA, NDRG1, ADM, BNIP3</td><td rowspan="1" colspan="1">TMEFF1, IVNS1ABP, TMEM45A, RRAGD</td></tr><tr><td rowspan="1" colspan="1">KEGG</td><td rowspan="1" colspan="1">Arginine and proline metabolism</td><td rowspan="1" colspan="1">6/35</td><td rowspan="1" colspan="1">4.E-05</td><td rowspan="1" colspan="1">P4HA2, NOS3, P4HA1, NOS2A</td><td rowspan="1" colspan="1">EPRS, ALDH4A1</td></tr><tr><td rowspan="1" colspan="1">Reactome</td><td rowspan="1" colspan="1">Platelet activation</td><td rowspan="1" colspan="1">7/86</td><td rowspan="1" colspan="1">1.E-02</td><td rowspan="1" colspan="1">PDGFA, TGFB3, FN1, VEGFA, ALDOA, SERPINE1</td><td rowspan="1" colspan="1">ARHGEF1</td></tr><tr><td rowspan="1" colspan="1">TargetScan</td><td rowspan="1" colspan="1">MiR-1/206</td><td rowspan="1" colspan="1">23/583</td><td rowspan="1" colspan="1">3.E-03</td><td rowspan="1" colspan="1">PDGFA, NAMPT, HSP90B1, MET, ETS1, VEGFA, EDN1, CITED2, STC2</td><td rowspan="1" colspan="1">RNF165, GRK6, SLC7A6, PTPLAD1, ASPH, MYLK, RSBN1, SLC31A1, EVI1, PGAM1, SOX6, BTAF1, MXD1, GLCCI1</td></tr><tr><td rowspan="1" colspan="1">Protein interactions</td><td rowspan="1" colspan="1">PCAF</td><td rowspan="1" colspan="1">10/106</td><td rowspan="1" colspan="1">9.E-05</td><td rowspan="1" colspan="1">ENO1, NR4A1, PFKL, PGK1</td><td rowspan="1" colspan="1">RARA, CCNB1, SSRP1, RBPJ, EVI1, BTAF1</td></tr></tbody>
###xml 1740 2564 1736 2560 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Source</th><th rowspan="1" colspan="1">Description</th><th rowspan="1" colspan="1">Number of genes</th><th colspan="2" rowspan="1">Previously validated HIF-1 targets<hr/></th><th rowspan="1" colspan="1">Novel HIF-1 targets</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"><italic>P</italic>-value</th><th rowspan="1" colspan="1">Gene symbols</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Protein domains</td><td rowspan="1" colspan="1">IPR005123; 2-oxoglutarate (2OG) and Fe(II)-dependent oxogenase</td><td rowspan="1" colspan="1">6/19</td><td rowspan="1" colspan="1">2.E-07</td><td rowspan="1" colspan="1">P4HA2, EGLN3, EGLN1, P4HA1, PH-4</td><td rowspan="1" colspan="1">PLOD1</td></tr><tr><td rowspan="1" colspan="1">GSEA</td><td rowspan="1" colspan="1">Poor progonosis marker genes in Breast Cancer</td><td rowspan="1" colspan="1">13/104</td><td rowspan="1" colspan="1">1.E-07</td><td rowspan="1" colspan="1">CA9, CP, PGK1, EGLN1, TFRC, VEGFA, NDRG1, ADM, BNIP3</td><td rowspan="1" colspan="1">TMEFF1, IVNS1ABP, TMEM45A, RRAGD</td></tr><tr><td rowspan="1" colspan="1">KEGG</td><td rowspan="1" colspan="1">Arginine and proline metabolism</td><td rowspan="1" colspan="1">6/35</td><td rowspan="1" colspan="1">4.E-05</td><td rowspan="1" colspan="1">P4HA2, NOS3, P4HA1, NOS2A</td><td rowspan="1" colspan="1">EPRS, ALDH4A1</td></tr><tr><td rowspan="1" colspan="1">Reactome</td><td rowspan="1" colspan="1">Platelet activation</td><td rowspan="1" colspan="1">7/86</td><td rowspan="1" colspan="1">1.E-02</td><td rowspan="1" colspan="1">PDGFA, TGFB3, FN1, VEGFA, ALDOA, SERPINE1</td><td rowspan="1" colspan="1">ARHGEF1</td></tr><tr><td rowspan="1" colspan="1">TargetScan</td><td rowspan="1" colspan="1">MiR-1/206</td><td rowspan="1" colspan="1">23/583</td><td rowspan="1" colspan="1">3.E-03</td><td rowspan="1" colspan="1">PDGFA, NAMPT, HSP90B1, MET, ETS1, VEGFA, EDN1, CITED2, STC2</td><td rowspan="1" colspan="1">RNF165, GRK6, SLC7A6, PTPLAD1, ASPH, MYLK, RSBN1, SLC31A1, EVI1, PGAM1, SOX6, BTAF1, MXD1, GLCCI1</td></tr><tr><td rowspan="1" colspan="1">Protein interactions</td><td rowspan="1" colspan="1">PCAF</td><td rowspan="1" colspan="1">10/106</td><td rowspan="1" colspan="1">9.E-05</td><td rowspan="1" colspan="1">ENO1, NR4A1, PFKL, PGK1</td><td rowspan="1" colspan="1">RARA, CCNB1, SSRP1, RBPJ, EVI1, BTAF1</td></tr></tbody></table>
###xml 2670 2671 2666 2667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2564 2821 2560 2817 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="60">The number of genes reflects the total number of known and predicted targets within the functional group. <italic>P</italic>-values for enrichment of validated HIF-1 targets were obtained using the hypergeometric distribution as described in &#8216;Materials and Methods&#8217; section.</p>
###xml 2564 2821 2560 2817 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="60">The number of genes reflects the total number of known and predicted targets within the functional group. <italic>P</italic>-values for enrichment of validated HIF-1 targets were obtained using the hypergeometric distribution as described in &#8216;Materials and Methods&#8217; section.</p></fn>
###xml 2564 2821 2560 2817 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn><p textid="60">The number of genes reflects the total number of known and predicted targets within the functional group. <italic>P</italic>-values for enrichment of validated HIF-1 targets were obtained using the hypergeometric distribution as described in &#8216;Materials and Methods&#8217; section.</p></fn></table-wrap-foot>
###xml 1599 2821 1595 2817 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T2" position="float"><label>Table 2.</label><caption><p textid="59">Selected examples of functional enrichment of 101 previously validated HIF-1 targets and mapping of novel targets to these categories</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Source</th><th rowspan="1" colspan="1">Description</th><th rowspan="1" colspan="1">Number of genes</th><th colspan="2" rowspan="1">Previously validated HIF-1 targets<hr/></th><th rowspan="1" colspan="1">Novel HIF-1 targets</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"><italic>P</italic>-value</th><th rowspan="1" colspan="1">Gene symbols</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Protein domains</td><td rowspan="1" colspan="1">IPR005123; 2-oxoglutarate (2OG) and Fe(II)-dependent oxogenase</td><td rowspan="1" colspan="1">6/19</td><td rowspan="1" colspan="1">2.E-07</td><td rowspan="1" colspan="1">P4HA2, EGLN3, EGLN1, P4HA1, PH-4</td><td rowspan="1" colspan="1">PLOD1</td></tr><tr><td rowspan="1" colspan="1">GSEA</td><td rowspan="1" colspan="1">Poor progonosis marker genes in Breast Cancer</td><td rowspan="1" colspan="1">13/104</td><td rowspan="1" colspan="1">1.E-07</td><td rowspan="1" colspan="1">CA9, CP, PGK1, EGLN1, TFRC, VEGFA, NDRG1, ADM, BNIP3</td><td rowspan="1" colspan="1">TMEFF1, IVNS1ABP, TMEM45A, RRAGD</td></tr><tr><td rowspan="1" colspan="1">KEGG</td><td rowspan="1" colspan="1">Arginine and proline metabolism</td><td rowspan="1" colspan="1">6/35</td><td rowspan="1" colspan="1">4.E-05</td><td rowspan="1" colspan="1">P4HA2, NOS3, P4HA1, NOS2A</td><td rowspan="1" colspan="1">EPRS, ALDH4A1</td></tr><tr><td rowspan="1" colspan="1">Reactome</td><td rowspan="1" colspan="1">Platelet activation</td><td rowspan="1" colspan="1">7/86</td><td rowspan="1" colspan="1">1.E-02</td><td rowspan="1" colspan="1">PDGFA, TGFB3, FN1, VEGFA, ALDOA, SERPINE1</td><td rowspan="1" colspan="1">ARHGEF1</td></tr><tr><td rowspan="1" colspan="1">TargetScan</td><td rowspan="1" colspan="1">MiR-1/206</td><td rowspan="1" colspan="1">23/583</td><td rowspan="1" colspan="1">3.E-03</td><td rowspan="1" colspan="1">PDGFA, NAMPT, HSP90B1, MET, ETS1, VEGFA, EDN1, CITED2, STC2</td><td rowspan="1" colspan="1">RNF165, GRK6, SLC7A6, PTPLAD1, ASPH, MYLK, RSBN1, SLC31A1, EVI1, PGAM1, SOX6, BTAF1, MXD1, GLCCI1</td></tr><tr><td rowspan="1" colspan="1">Protein interactions</td><td rowspan="1" colspan="1">PCAF</td><td rowspan="1" colspan="1">10/106</td><td rowspan="1" colspan="1">9.E-05</td><td rowspan="1" colspan="1">ENO1, NR4A1, PFKL, PGK1</td><td rowspan="1" colspan="1">RARA, CCNB1, SSRP1, RBPJ, EVI1, BTAF1</td></tr></tbody></table><table-wrap-foot><fn><p textid="60">The number of genes reflects the total number of known and predicted targets within the functional group. <italic>P</italic>-values for enrichment of validated HIF-1 targets were obtained using the hypergeometric distribution as described in &#8216;Materials and Methods&#8217; section.</p></fn></table-wrap-foot></table-wrap>
###xml 1113 1118 <span type="species:ncbi:9606">human</span>
All previously validated HIF-1 targets () were tested for functional enrichment in KEGG pathway databases, Reactome database, Gene Set Enrichment Molecular Database (GSEA), protein interactions, InterPro protein domains and microRNA-target prediction database TargetScan (see 'Materials and Methods' section). This analysis allows identification of pathways or attributes that are highly represented by the HIF targets compared to an equivalent random list of genes. We next mapped novel HIF targets to these significantly enriched attributes as demonstrated by selected examples in Table 2 (full analysis shown in ). Analysis of protein domains identified 2-oxoglutarate and Fe(II)-dependent oxygenase family as highly enriched in validated HIF targets (5 of 19 proteins, P < 2e-7). This family includes the prolyl hydroxylases known to regulate HIF-1alpha as part of the oxygen sensing mechanism. PLOD1, is a novel predicted HIF target that is part of the same family. Analysis of microRNA targets identified five microRNAs that target validated HIF targets. miR-1/206, for instance, is predicted to target 583 human genes, of which nine are known to be HIF-1 targets and 14 are predicted HIF targets. Analysis of gene sets from GSEA highlighted a group of 104 genes that predict a poor breast cancer prognosis and included nine validated HIF targets (P = 1e-7) and four predicted ones. A graphical representation of protein interactions and Reactome pathways is shown in Figure 4C and D and highlights genes such as PCAF. PCAF interacts with four validated HIF targets and six predicted targets. Table 2.Selected examples of functional enrichment of 101 previously validated HIF-1 targets and mapping of novel targets to these categoriesSourceDescriptionNumber of genesPreviously validated HIF-1 targetsNovel HIF-1 targetsP-valueGene symbolsProtein domainsIPR005123; 2-oxoglutarate (2OG) and Fe(II)-dependent oxogenase6/192.E-07P4HA2, EGLN3, EGLN1, P4HA1, PH-4PLOD1GSEAPoor progonosis marker genes in Breast Cancer13/1041.E-07CA9, CP, PGK1, EGLN1, TFRC, VEGFA, NDRG1, ADM, BNIP3TMEFF1, IVNS1ABP, TMEM45A, RRAGDKEGGArginine and proline metabolism6/354.E-05P4HA2, NOS3, P4HA1, NOS2AEPRS, ALDH4A1ReactomePlatelet activation7/861.E-02PDGFA, TGFB3, FN1, VEGFA, ALDOA, SERPINE1ARHGEF1TargetScanMiR-1/20623/5833.E-03PDGFA, NAMPT, HSP90B1, MET, ETS1, VEGFA, EDN1, CITED2, STC2RNF165, GRK6, SLC7A6, PTPLAD1, ASPH, MYLK, RSBN1, SLC31A1, EVI1, PGAM1, SOX6, BTAF1, MXD1, GLCCI1Protein interactionsPCAF10/1069.E-05ENO1, NR4A1, PFKL, PGK1RARA, CCNB1, SSRP1, RBPJ, EVI1, BTAF1The number of genes reflects the total number of known and predicted targets within the functional group. P-values for enrichment of validated HIF-1 targets were obtained using the hypergeometric distribution as described in 'Materials and Methods' section.
###end p 58
###begin p 59
Selected examples of functional enrichment of 101 previously validated HIF-1 targets and mapping of novel targets to these categories
###end p 59
###begin p 60
###xml 106 107 106 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The number of genes reflects the total number of known and predicted targets within the functional group. P-values for enrichment of validated HIF-1 targets were obtained using the hypergeometric distribution as described in 'Materials and Methods' section.
###end p 60
###begin title 61
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
ANKRD37 is a novel HIF-target gene
###end title 61
###begin p 62
###xml 155 162 155 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KLF10</italic>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WSB1</italic>
###xml 211 215 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GYS1</italic>
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELL2</italic>
###xml 275 282 275 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 342 347 342 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KLF10</italic>
###xml 364 368 364 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WSB1</italic>
###xml 385 389 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GYS1</italic>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELL2</italic>
###xml 442 447 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
###xml 512 520 512 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 537 544 537 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 656 663 656 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 790 797 790 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 1041 1048 1041 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 1146 1154 1146 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1158 1165 1158 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 1285 1290 1285 1290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
###xml 1451 1459 1451 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1475 1480 1475 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
###xml 1606 1611 1606 1611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
###xml 1623 1631 1623 1631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1635 1644 1635 1644 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 1644 1651 1644 1651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 1674 1675 1674 1675 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1677 1684 1677 1684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 1773 1774 1773 1774 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1776 1777 1776 1777 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1779 1786 1779 1786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 1846 1851 1846 1851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF1A</italic>
###xml 1959 1966 1959 1966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 1971 1976 1971 1976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
###xml 1644 2039 1644 2039 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="63"><italic>ANKRD37</italic> response to hypoxia. (<bold>A</bold>) <italic>ANKRD37</italic> mRNA levels were monitored by qPCR across seven cell lines and normalized to 18S rRNA. (<bold>B</bold>, <bold>C</bold>) <italic>ANKRD37</italic> hypoxic induction over time during hypoxia. (B) Endogenous <italic>HIF1A</italic> protein levels determined after 0, 4, 8 and 12 h of hypoxic incubation by western blot. (C) mRNA levels of <italic>ANKRD37</italic> and <italic>VEGFA</italic> measured by qPCR after 0, 4, 8 and 12 h of hypoxic incubation.</p>
###xml 1644 2039 1644 2039 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="63"><italic>ANKRD37</italic> response to hypoxia. (<bold>A</bold>) <italic>ANKRD37</italic> mRNA levels were monitored by qPCR across seven cell lines and normalized to 18S rRNA. (<bold>B</bold>, <bold>C</bold>) <italic>ANKRD37</italic> hypoxic induction over time during hypoxia. (B) Endogenous <italic>HIF1A</italic> protein levels determined after 0, 4, 8 and 12 h of hypoxic incubation by western blot. (C) mRNA levels of <italic>ANKRD37</italic> and <italic>VEGFA</italic> measured by qPCR after 0, 4, 8 and 12 h of hypoxic incubation.</p></caption>
###xml 2039 2039 2039 2039 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp425f5"/>
###xml 1635 2039 1635 2039 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="63"><italic>ANKRD37</italic> response to hypoxia. (<bold>A</bold>) <italic>ANKRD37</italic> mRNA levels were monitored by qPCR across seven cell lines and normalized to 18S rRNA. (<bold>B</bold>, <bold>C</bold>) <italic>ANKRD37</italic> hypoxic induction over time during hypoxia. (B) Endogenous <italic>HIF1A</italic> protein levels determined after 0, 4, 8 and 12 h of hypoxic incubation by western blot. (C) mRNA levels of <italic>ANKRD37</italic> and <italic>VEGFA</italic> measured by qPCR after 0, 4, 8 and 12 h of hypoxic incubation.</p></caption><graphic xlink:href="gkp425f5"/></fig>
###xml 779 788 <span type="species:ncbi:7955">zebrafish</span>
To demonstrate the utility of our method in identifying novel HIF-1-target genes, we selected five genes that were previously unknown to be HIF-1 targets, ANKRD37 (ranked 8), KLF10 (ranked 24) WSB1 (ranked 32), GYS1 (ranked 34) and ELL2 (ranked 465). Using quantitative PCR, ANKRD37 was induced up to 35-fold in hypoxia compared to normoxia, KLF10 up to 2.5-fold, WSB1 up to 4.9-fold, GYS1 up to 7.8-fold, ELL2 was not induced in hypoxia and VEGFA that was used as a positive control was induced up to 8.3-fold (Figure 5 and ). The gene ANKRD37 was studied further due to its extreme induction in hypoxia and its high ranking within the predicted targets. ANKRD37 is a short (158 amino acids, 17 kDa) ankyrin repeat protein with unknown function that is conserved in mammals and zebrafish. ANKRD37 responded to hypoxia in four of six cell types and four HIF-1-binding sites were predicted within the proximal promoter. The response to hypoxia was validated under hypoxic conditions across seven cell lines. We observed a strong induction of ANKRD37 in all cell lines but most significantly in the colon cancer cell lines DLD-1, HCT116 and SW480 (Figure 5A). ANKRD37 hypoxic induction was measured after 4, 8 and 12 h of incubation in hypoxic conditions in HCT116 cells and compared to VEGFA. HIF-1 protein levels were determined by western blot and showed a significant induction after 4 and 8 h compared to normoxia and a slight decrease after 12 h (Figure 5B). ANKRD37 and VEGFA mRNA levels showed a similar profile that matched the HIF-1 induction; however, ANKRD37 was induced 3-fold over the level of VEGFA induction (Figure 5C). Figure 5.ANKRD37 response to hypoxia. (A) ANKRD37 mRNA levels were monitored by qPCR across seven cell lines and normalized to 18S rRNA. (B, C) ANKRD37 hypoxic induction over time during hypoxia. (B) Endogenous HIF1A protein levels determined after 0, 4, 8 and 12 h of hypoxic incubation by western blot. (C) mRNA levels of ANKRD37 and VEGFA measured by qPCR after 0, 4, 8 and 12 h of hypoxic incubation.
###end p 62
###begin p 63
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 30 31 30 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 129 130 129 130 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 132 133 132 133 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 135 142 135 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 202 207 202 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF1A</italic>
###xml 315 322 315 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
ANKRD37 response to hypoxia. (A) ANKRD37 mRNA levels were monitored by qPCR across seven cell lines and normalized to 18S rRNA. (B, C) ANKRD37 hypoxic induction over time during hypoxia. (B) Endogenous HIF1A protein levels determined after 0, 4, 8 and 12 h of hypoxic incubation by western blot. (C) mRNA levels of ANKRD37 and VEGFA measured by qPCR after 0, 4, 8 and 12 h of hypoxic incubation.
###end p 63
###begin p 64
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 280 288 280 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 297 304 297 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 624 632 624 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 723 730 723 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 790 795 790 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF1A</italic>
###xml 814 819 814 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF1A</italic>
###xml 953 958 953 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIF1A</italic>
###xml 1177 1180 1177 1180 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AAA</underline>
###xml 1196 1204 1196 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1339 1348 1339 1348 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 1373 1380 1373 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 1392 1393 1392 1393 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1463 1470 1463 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 1662 1669 1662 1669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 1907 1909 1907 1909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B95">95</xref>
###xml 1913 1914 1913 1914 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2238 2239 2236 2237 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2451 2452 2449 2450 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2454 2462 2452 2460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 2505 2512 2503 2510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 2898 2901 2896 2899 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AAA</underline>
###xml 2983 2984 2981 2982 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 3222 3223 3212 3213 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 3225 3232 3215 3222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In-vivo</italic>
###xml 3280 3287 3266 3273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 1348 3667 1348 3649 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="65">Mapping of HIF-1 site in <italic>ANKRD37</italic> promoter. (<bold>A</bold>) Genome browser view of the four HIF-binding sites identified in the <italic>ANKRD37</italic> promoters and the three promoter sequences that were cloned to identify the dominant HIF-1 site. The site score is shown in parenthesis for each site, higher is better. The larger box of the <italic>ANKRD37</italic> transcript (green) indicates the coding sequence. Note that the conservation shown on the plot is computed by PhastCons which scores conservation based on the evolutionary distance and does not necessarily reflect the number of species (<xref ref-type="bibr" rid="B95">95</xref>). (<bold>B</bold>) DLD1, HCT116 and MCF7 cells were transiently transfected and incubated under normoxic or hypoxic conditions. Luciferase activity of the three promoters was measured and normalized to promoter 1 in normoxic conditions. All studies were performed in triplicate and data represent the mean &#177; SD for three different wells. (<bold>C</bold>) Luciferase activity of promoter 1 in normoxia versus hypoxia with mutations in sites 1, 2 and 4 in DLD1, HCT116 and MCF7 cells. Experimental procedure and data analysis was performed as described for panel B. (<bold>D</bold>) <italic>In vitro</italic> binding of HIF-1 protein to site 2 in the <italic>ANKRD37</italic> promoter. EMSAs were performed using biotinylated probe corresponding to HIF-binding site 2. Nuclear extracts (NE) from MCF7 cells cultured in either normoxia (N) or hypoxia (H) were utilized. The asterisk indicates the specific shift obtained in hypoxia. 200&#215; M excess of non-labeled probe as a specific competitor or probe with a specific mutation in the HIF-binding site2 (ACGTG &gt; A<underline>AAA</underline>G) was utilized to confirm specificity. WT = wild-type probe. MT = mutant probe. (<bold>E</bold>) Nuclear extracts from MCF7 cells grown in hypoxia were incubated with antibody specific to HIF-1&#945; or normal mouse IgG. The double asterisk indicates the super-shift obtained only with a HIF-1&#945; antibody. N.S.; nonspecific band. (<bold>F</bold>) <italic>In-vivo</italic> binding of HIF-1&#945; protein to site 2 in the <italic>ANKRD37</italic> promoter. ChIP assays were performed using primer sets corresponding to HIF-binding site 2 (primer A) or a region upstream of site 2 (primer B). DNA&#8211;protein complexes from MCF7 cells cultured in either normoxia (N) or hypoxia (H) were immunoprecipitated with or without antibody specific to HIF-1&#945; or normal mouse IgG. Precipitated DNA or input samples were amplified by PCR.</p>
###xml 1348 3667 1348 3649 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="65">Mapping of HIF-1 site in <italic>ANKRD37</italic> promoter. (<bold>A</bold>) Genome browser view of the four HIF-binding sites identified in the <italic>ANKRD37</italic> promoters and the three promoter sequences that were cloned to identify the dominant HIF-1 site. The site score is shown in parenthesis for each site, higher is better. The larger box of the <italic>ANKRD37</italic> transcript (green) indicates the coding sequence. Note that the conservation shown on the plot is computed by PhastCons which scores conservation based on the evolutionary distance and does not necessarily reflect the number of species (<xref ref-type="bibr" rid="B95">95</xref>). (<bold>B</bold>) DLD1, HCT116 and MCF7 cells were transiently transfected and incubated under normoxic or hypoxic conditions. Luciferase activity of the three promoters was measured and normalized to promoter 1 in normoxic conditions. All studies were performed in triplicate and data represent the mean &#177; SD for three different wells. (<bold>C</bold>) Luciferase activity of promoter 1 in normoxia versus hypoxia with mutations in sites 1, 2 and 4 in DLD1, HCT116 and MCF7 cells. Experimental procedure and data analysis was performed as described for panel B. (<bold>D</bold>) <italic>In vitro</italic> binding of HIF-1 protein to site 2 in the <italic>ANKRD37</italic> promoter. EMSAs were performed using biotinylated probe corresponding to HIF-binding site 2. Nuclear extracts (NE) from MCF7 cells cultured in either normoxia (N) or hypoxia (H) were utilized. The asterisk indicates the specific shift obtained in hypoxia. 200&#215; M excess of non-labeled probe as a specific competitor or probe with a specific mutation in the HIF-binding site2 (ACGTG &gt; A<underline>AAA</underline>G) was utilized to confirm specificity. WT = wild-type probe. MT = mutant probe. (<bold>E</bold>) Nuclear extracts from MCF7 cells grown in hypoxia were incubated with antibody specific to HIF-1&#945; or normal mouse IgG. The double asterisk indicates the super-shift obtained only with a HIF-1&#945; antibody. N.S.; nonspecific band. (<bold>F</bold>) <italic>In-vivo</italic> binding of HIF-1&#945; protein to site 2 in the <italic>ANKRD37</italic> promoter. ChIP assays were performed using primer sets corresponding to HIF-binding site 2 (primer A) or a region upstream of site 2 (primer B). DNA&#8211;protein complexes from MCF7 cells cultured in either normoxia (N) or hypoxia (H) were immunoprecipitated with or without antibody specific to HIF-1&#945; or normal mouse IgG. Precipitated DNA or input samples were amplified by PCR.</p></caption>
###xml 3667 3667 3649 3649 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp425f6"/>
###xml 1339 3667 1339 3649 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="65">Mapping of HIF-1 site in <italic>ANKRD37</italic> promoter. (<bold>A</bold>) Genome browser view of the four HIF-binding sites identified in the <italic>ANKRD37</italic> promoters and the three promoter sequences that were cloned to identify the dominant HIF-1 site. The site score is shown in parenthesis for each site, higher is better. The larger box of the <italic>ANKRD37</italic> transcript (green) indicates the coding sequence. Note that the conservation shown on the plot is computed by PhastCons which scores conservation based on the evolutionary distance and does not necessarily reflect the number of species (<xref ref-type="bibr" rid="B95">95</xref>). (<bold>B</bold>) DLD1, HCT116 and MCF7 cells were transiently transfected and incubated under normoxic or hypoxic conditions. Luciferase activity of the three promoters was measured and normalized to promoter 1 in normoxic conditions. All studies were performed in triplicate and data represent the mean &#177; SD for three different wells. (<bold>C</bold>) Luciferase activity of promoter 1 in normoxia versus hypoxia with mutations in sites 1, 2 and 4 in DLD1, HCT116 and MCF7 cells. Experimental procedure and data analysis was performed as described for panel B. (<bold>D</bold>) <italic>In vitro</italic> binding of HIF-1 protein to site 2 in the <italic>ANKRD37</italic> promoter. EMSAs were performed using biotinylated probe corresponding to HIF-binding site 2. Nuclear extracts (NE) from MCF7 cells cultured in either normoxia (N) or hypoxia (H) were utilized. The asterisk indicates the specific shift obtained in hypoxia. 200&#215; M excess of non-labeled probe as a specific competitor or probe with a specific mutation in the HIF-binding site2 (ACGTG &gt; A<underline>AAA</underline>G) was utilized to confirm specificity. WT = wild-type probe. MT = mutant probe. (<bold>E</bold>) Nuclear extracts from MCF7 cells grown in hypoxia were incubated with antibody specific to HIF-1&#945; or normal mouse IgG. The double asterisk indicates the super-shift obtained only with a HIF-1&#945; antibody. N.S.; nonspecific band. (<bold>F</bold>) <italic>In-vivo</italic> binding of HIF-1&#945; protein to site 2 in the <italic>ANKRD37</italic> promoter. ChIP assays were performed using primer sets corresponding to HIF-binding site 2 (primer A) or a region upstream of site 2 (primer B). DNA&#8211;protein complexes from MCF7 cells cultured in either normoxia (N) or hypoxia (H) were immunoprecipitated with or without antibody specific to HIF-1&#945; or normal mouse IgG. Precipitated DNA or input samples were amplified by PCR.</p></caption><graphic xlink:href="gkp425f6"/></fig>
###xml 3098 3103 <span type="species:ncbi:10090">mouse</span>
###xml 3600 3605 <span type="species:ncbi:10090">mouse</span>
We next investigated the HIF-binding sites in the ANKRD37 promoter. We identified four HIF-1-binding sites that matched our filtering criteria and were located at -311 to -306 bp (site 1), -228 to -223 bp (site 2), -142 to -137 bp (site 3) and +12 to +17 bp (site 4). As shown in Figure 6A, three ANKRD37 promoters encompassing these different HIF-binding sites were cloned upstream of a luciferase reporter. Promoter 1 was induced 4.1, 7.4 and 10.7-fold in hypoxia compared to normoxia in DLD-1, HCT116 and MCF7 cells, respectively. In contrast the induction observed with promoters 2 and 3 was in the range of 1.5-3-fold (Figure 6B). To determine whether the hypoxia induction was HIF-1 dependent, luciferase activity of ANKRD37 promoter 1 was measured in HCT116 cells in the presence of HIF1A siRNA. Endogenous HIF1A knockdown was confirmed by western blot (). The 5-fold induction of promoter 1 in hypoxia was reduced to 1.3-fold in the presence of HIF1A siRNA (). These results suggested that sites 1 and 2 are the physiologically relevant HIF-1-binding sites. Therefore, sites 1, 2 and 4 in promoter 1 were selectively mutated at the HIF consensus-binding site (ACGTG > AAAAG). As shown in Figure 6C, the hypoxic induction of promoter 1 was maximally inhibited by a mutation in site 2 while the other mutations had a minimal effect. Figure 6.Mapping of HIF-1 site in ANKRD37 promoter. (A) Genome browser view of the four HIF-binding sites identified in the ANKRD37 promoters and the three promoter sequences that were cloned to identify the dominant HIF-1 site. The site score is shown in parenthesis for each site, higher is better. The larger box of the ANKRD37 transcript (green) indicates the coding sequence. Note that the conservation shown on the plot is computed by PhastCons which scores conservation based on the evolutionary distance and does not necessarily reflect the number of species (95). (B) DLD1, HCT116 and MCF7 cells were transiently transfected and incubated under normoxic or hypoxic conditions. Luciferase activity of the three promoters was measured and normalized to promoter 1 in normoxic conditions. All studies were performed in triplicate and data represent the mean +/- SD for three different wells. (C) Luciferase activity of promoter 1 in normoxia versus hypoxia with mutations in sites 1, 2 and 4 in DLD1, HCT116 and MCF7 cells. Experimental procedure and data analysis was performed as described for panel B. (D) In vitro binding of HIF-1 protein to site 2 in the ANKRD37 promoter. EMSAs were performed using biotinylated probe corresponding to HIF-binding site 2. Nuclear extracts (NE) from MCF7 cells cultured in either normoxia (N) or hypoxia (H) were utilized. The asterisk indicates the specific shift obtained in hypoxia. 200x M excess of non-labeled probe as a specific competitor or probe with a specific mutation in the HIF-binding site2 (ACGTG > AAAAG) was utilized to confirm specificity. WT = wild-type probe. MT = mutant probe. (E) Nuclear extracts from MCF7 cells grown in hypoxia were incubated with antibody specific to HIF-1alpha or normal mouse IgG. The double asterisk indicates the super-shift obtained only with a HIF-1alpha antibody. N.S.; nonspecific band. (F) In-vivo binding of HIF-1alpha protein to site 2 in the ANKRD37 promoter. ChIP assays were performed using primer sets corresponding to HIF-binding site 2 (primer A) or a region upstream of site 2 (primer B). DNA-protein complexes from MCF7 cells cultured in either normoxia (N) or hypoxia (H) were immunoprecipitated with or without antibody specific to HIF-1alpha or normal mouse IgG. Precipitated DNA or input samples were amplified by PCR.
###end p 64
###begin p 65
###xml 25 32 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 44 45 44 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 115 122 115 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 314 321 314 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B95">95</xref>
###xml 565 566 565 566 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 890 891 888 889 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1103 1104 1101 1102 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1106 1114 1104 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1157 1164 1155 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 1550 1553 1548 1551 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AAA</underline>
###xml 1635 1636 1633 1634 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1874 1875 1864 1865 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1877 1884 1867 1874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In-vivo</italic>
###xml 1932 1939 1918 1925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 1750 1755 <span type="species:ncbi:10090">mouse</span>
###xml 2252 2257 <span type="species:ncbi:10090">mouse</span>
Mapping of HIF-1 site in ANKRD37 promoter. (A) Genome browser view of the four HIF-binding sites identified in the ANKRD37 promoters and the three promoter sequences that were cloned to identify the dominant HIF-1 site. The site score is shown in parenthesis for each site, higher is better. The larger box of the ANKRD37 transcript (green) indicates the coding sequence. Note that the conservation shown on the plot is computed by PhastCons which scores conservation based on the evolutionary distance and does not necessarily reflect the number of species (95). (B) DLD1, HCT116 and MCF7 cells were transiently transfected and incubated under normoxic or hypoxic conditions. Luciferase activity of the three promoters was measured and normalized to promoter 1 in normoxic conditions. All studies were performed in triplicate and data represent the mean +/- SD for three different wells. (C) Luciferase activity of promoter 1 in normoxia versus hypoxia with mutations in sites 1, 2 and 4 in DLD1, HCT116 and MCF7 cells. Experimental procedure and data analysis was performed as described for panel B. (D) In vitro binding of HIF-1 protein to site 2 in the ANKRD37 promoter. EMSAs were performed using biotinylated probe corresponding to HIF-binding site 2. Nuclear extracts (NE) from MCF7 cells cultured in either normoxia (N) or hypoxia (H) were utilized. The asterisk indicates the specific shift obtained in hypoxia. 200x M excess of non-labeled probe as a specific competitor or probe with a specific mutation in the HIF-binding site2 (ACGTG > AAAAG) was utilized to confirm specificity. WT = wild-type probe. MT = mutant probe. (E) Nuclear extracts from MCF7 cells grown in hypoxia were incubated with antibody specific to HIF-1alpha or normal mouse IgG. The double asterisk indicates the super-shift obtained only with a HIF-1alpha antibody. N.S.; nonspecific band. (F) In-vivo binding of HIF-1alpha protein to site 2 in the ANKRD37 promoter. ChIP assays were performed using primer sets corresponding to HIF-binding site 2 (primer A) or a region upstream of site 2 (primer B). DNA-protein complexes from MCF7 cells cultured in either normoxia (N) or hypoxia (H) were immunoprecipitated with or without antibody specific to HIF-1alpha or normal mouse IgG. Precipitated DNA or input samples were amplified by PCR.
###end p 65
###begin p 66
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 348 356 348 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 509 512 509 512 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AAA</underline>
###xml 579 587 579 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 860 868 852 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1234 1241 1218 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 1603 1611 1579 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 722 727 <span type="species:ncbi:10090">mouse</span>
###xml 1156 1161 <span type="species:ncbi:10090">mouse</span>
To establish whether endogenous HIF-1 protein binds to site 2 in the ANKRD37 promoter, EMSA assays were performed using nuclear extracts from MCF7 cells incubated in either normoxia or hypoxia. A unique band shift was obtained only when nuclear extracts from cells grown in hypoxic conditions were incubated with the probe corresponding to site 2 (Figure 6D, lane 3). When non-biotinylated probe was co-incubated as a competitor, or a probe with specific mutations in the HIF consensus-binding site (ACGTG > AAAAG) was utilized, the band obtained in hypoxic conditions was lost (Figure 6D, lanes 4 and 5). Nuclear extracts from cells grown in hypoxia were then incubated with an antibody specific to HIF-1alpha or control mouse IgG prior to performing EMSA assays. Incubation with an antibody against HIF-1alpha resulted in a supershift of this specific band (Figure 6E). To further address whether HIF-1alpha physiologically binds to site 2, chromatin immunoprecipitation assays were performed using MCF7 cells incubated in either normoxia or hypoxia. Cross-linked cell lysates were immunoprecipitated with or without anti- HIF-1alpha antibody or control mouse IgG and PCR was performed to amplify a 178 bp or 220 bp fragment of the ANKRD37 promoter using primers corresponding to site 2 (primers A) and a region upstream of site 2 (primers B), respectively. DNA bound to HIF-1alpha was detected when DNA-protein complexes from hypoxic cells were precipitated with an anti-HIF-1alpha antibody and amplified with primers A, whereas no binding was observed at an upstream promoter region with primers B (Figure 6F). These data indicate that site 2, the most conserved and highest scoring HIF site, is indeed a HIF-1-binding site in DLD-1, HCT116 and MCF7 cells.
###end p 66
###begin title 67
The HIF-transcriptional network
###end title 67
###begin p 68
###xml 496 497 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 501 502 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</italic>
###xml 591 592 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 702 703 702 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1090 1091 1090 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1345 1349 1345 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATF2</italic>
###xml 1351 1356 1351 1356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CREB1</italic>
###xml 1358 1361 1358 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP1</italic>
###xml 1363 1366 1363 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT1</italic>
###xml 1371 1374 1371 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JUN</italic>
###xml 1899 1900 1899 1900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2088 2093 2088 2093 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCF2</italic>
###xml 2095 2099 2095 2099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYCS</italic>
###xml 2101 2103 2101 2103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FH</italic>
###xml 2105 2110 2105 2110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MRPL4</italic>
To identify transcription factors that are part of the HIF network we analyzed the presence of other binding sites in the 81 genes that ranked in top 200 and responded to hypoxia in at least three cell types. Matrices for validated transcription factors from the TRANSFAC and Jaspar collections were used to identify binding sites within 150 bases away from the highest scoring HIF-binding site in each of the promoters as well as within the entire promoter. For this analysis we used STORM with P < 1e-4 and accepted only binding sites predicted in at least four species and significantly (P < 0.05) more conserved compared to the flanking 100 bases (see 'Materials and Methods' section). To obtain a P-value for co-occurring binding sites, a chi-square analysis was performed compared to TFBS occurrence in a background set of 1000 promoters of genes that responded to hypoxia in at least one cell type but had no detectable HIF binding (see 'Materials and Methods' section). The analysis was performed in increments of 25 bases from the highest scoring HIF site and the most significant P-value for each PWM was selected. Only binding sites that were not predicted at the HIF consensus binding site were considered. We identified 10 TFBS that were significantly enriched within a specific distance from the highest scoring HIF site including ATF2, CREB1, SP1, WT1 and JUN which have been previously linked to hypoxia and HIF-1 (). When considering the entire promoter, we observed enrichment for P53:P73-binding sites and multiple members of the forkhead family, including FOXO4, FOXD1 and FOXF2. To test for potential mechanism in up or down regulation of HIF-target genes, a similar analysis was employed to upregulated and downregulated transcripts separately. Most of the sites co-occurring for all HIF targets above were also enriched for the upregulated genes, albeit with more significant P-values. SP-1 and NF-Y were the only TFs significantly co-occurring within a specific distance from the HIF site in downregulated genes. Surprisingly, four of five predicted NF-Y targets (ABCF2, CYCS, FH, MRPL4) were genes localized to mitochondria ().
###end p 68
###begin title 69
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de-novo</italic>
HIF-1 motifs are identified de-novo in predicted HIF-1-target genes
###end title 69
###begin p 70
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de-novo</italic>
###xml 536 543 536 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de-novo</italic>
###xml 614 621 614 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de-novo</italic>
###xml 742 749 742 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de-novo</italic>
###xml 813 817 813 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARNT</italic>
###xml 831 835 828 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATF2</italic>
###xml 846 850 843 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATF6</italic>
###xml 925 932 922 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de-novo</italic>
###xml 941 946 938 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CREB1</italic>
###xml 957 961 954 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EVI1</italic>
###xml 966 970 963 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MIZF</italic>
To identify de-novo motifs over-represented in the promoters of the 81 HIF-target genes selected above, DME2 was employed. For each motif length in the range of 5-12 bases we identified the top 50 over-represented motifs compared to a suitable background set (see 'Materials and Methods' section). These motifs were compared to the TRANSFAC and Jaspar collections of PWMs using the CREAD program MATCOMPARE. Comparison was estimated using a divergence score in the range of 0 to 1, where a divergence of 0 indicates the motif predicted de-novo is identical to a PWM. HIF-1 PWMs were matched best to six bases long de-novo motifs. For motifs longer than 7 bases, no HIF-1 PWMs were ranked within the top 50 (). Comparing all available PWMs to de-novo predicted motifs with a divergence of 0.25 or lower identified ARNT (HIF-1beta), ATF2, NF-Y and ATF6 as the most enriched in the data set (). Other motifs that were predicted de-novo include CREB1, AP-1 and EVI1 and MIZF (). Some of these are also identified above as part of the HIF-transcriptional network.
###end p 70
###begin title 71
DISCUSSION
###end title 71
###begin p 72
###xml 347 354 347 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 356 363 356 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B67">67</xref>
###xml 606 610 602 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 612 617 608 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68 B69 B70">68&#8211;70</xref>
###xml 620 627 616 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
###xml 661 666 657 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
###xml 668 676 664 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 855 862 851 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANKRD37</italic>
In this study we presented a computational strategy to identify HIF-1-target genes. This strategy integrates gene expression profiles and computational-binding site analysis of proximal promoters. The utility of our strategy in detecting novel HIF-target genes was demonstrated by recovering known HIF-1-target genes and experimentally validating ANKRD37. ANKRD37 is a previously uncharacterized protein that contains four ankyrin repeats. Ankyrin repeats are thought to mediate protein-protein interactions (67) and are known to be involved in regulation of key transcription factors such as NFkappaB and TP53 (68-70). ANKRD37 induction was 3-fold higher than VEGFA (Figure 5E), the validated HIF-1-binding site was conserved in 10 species and was significantly induced in hypoxia in multiple cell types analyzed here. Taken together, these data suggest ANKRD37 is likely to have an important role in the hypoxia response.
###end p 72
###begin p 73
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B71">71</xref>
###xml 945 950 945 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DEAF1</italic>
###xml 952 956 952 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELK1</italic>
###xml 958 964 958 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">POU2F1</italic>
###xml 969 973 969 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF1</italic>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B72">72</xref>
###xml 978 980 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B73">73</xref>
###xml 1493 1501 1493 1501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC25A28</italic>
###xml 1547 1551 1547 1551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ISCU</italic>
###xml 1752 1753 1752 1753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 1918 1923 1918 1923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MRPL4</italic>
###xml 1928 1934 1928 1934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MRPS12</italic>
###xml 2101 2104 2101 2104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAD</italic>
###xml 2143 2145 2143 2145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B74">74</xref>
###xml 2148 2152 2148 2152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RRP9</italic>
###xml 2254 2256 2254 2256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B75">75</xref>
###xml 2259 2265 2259 2265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIF2B3</italic>
###xml 2312 2317 2312 2317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCNB1</italic>
###xml 2361 2363 2361 2363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B74">74</xref>
###xml 2461 2465 2461 2465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GYS1</italic>
###xml 2509 2511 2509 2511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 2512 2514 2512 2514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B76">76</xref>
The cellular response to hypoxia was different between cell types, consistent with previous reports (55,56). The union of all differentially expressed genes in the data sets presented here contained over 6000 unique genes. Even when comparing studies that attempted to detect a HIF dependent response to hypoxia (21,22,71), only 45 genes were differentially expressed in all three. Importantly the analysis presented here indicates that 60% of the transcripts that responded to hypoxia did not have a detectable conserved HIF-binding site in their proximal promoter. This observation was also supported by MOTIFCLASS enrichment, which is an independent analysis that does not consider conservation and did not detect any enrichment for HIF-binding sites in those promoters. In addition, transcripts with no detectable HIF site were enriched for other TFBS that were previously shown to participate in the cellular response to hypoxia including, DEAF1, ELK1, POU2F1 and IRF1 (72,73). Moreover, genes that responded to hypoxia and did not have a detectable HIF-binding site were used as a background for the HIF-1-transcriptional network. One possible mechanism that may explain the different hypoxic response between cells is that genes directly regulated by HIF are involved in key processes and their regulation mediates a robust effect. As illustrated in the mitochondrial map, where several predicted downregulated genes affect key steps in the mitochondria. The predicted HIF-target genes SLC25A28, an iron transporter in the mitochondria and ISCU, an iron-sulfur scaffold protein are both downregulated in hypoxia. These two genes could affect several of the mitochondria iron-sulfur proteins including, NADH dehydrogenease, Coenzyme Q-cytochrome c reductase and Succinate-coenzyme Q reductase are critical to the function of the electron transport chain and the TCA cycle. In addition, the predicted HIF targets MRPL4 and MRPS12 are components of the mitochondrial ribosome that are required for mitochondrial protein translation. Additional examples include cell growth arrest by inhibition of CAD, a component of pyrimidine synthesis (74); RRP9, a component of snoRNP predicted to participate in processing and modification of pre-ribosomal RNA (75); EIF2B3, a translation initiation factor subunit; and CCNB1, a regulatory protein involved in mitosis (74). One novel predicted HIF target that is highlighted by the HIF-1 KEGG metabolic pathways map is GYS1, a gene involved in glycogen biosynthesis (65,76) that was validated as responsive to hypoxia by quantitative PCR in multiple cell types.
###end p 73
###begin p 74
###xml 556 561 552 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGLN1</italic>
###xml 566 571 562 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGLN3</italic>
###xml 598 603 594 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLOD1</italic>
###xml 731 733 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B77">77</xref>
###xml 749 754 745 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLOD1</italic>
###xml 873 875 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B78">78</xref>
###xml 1132 1134 1128 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B79">79</xref>
###xml 1184 1186 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B80">80</xref>
###xml 1387 1395 1383 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1734 1736 1726 1728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B81">81</xref>
###xml 466 471 <span type="species:ncbi:9606">human</span>
###xml 1096 1099 <span type="species:ncbi:10116">rat</span>
To highlight predicted HIF targets of interest and to suggest potential functional roles for these targets, a bioinformatics analysis of validated HIF targets was performed and predicted targets that were not previously validated were mapped to the significantly enriched functional categories. This analysis is summarized in  and identifies several attractive predicted HIF targets. The family of 2-oxoglutarate and Fe(II)-dependent oxygenase has 19 members in the human genome of which five are bona fide HIF targets, including the HIF-1alpha regulators EGLN1 and EGLN3. The predicted HIF target PLOD1, is a member of that family and a lysyl hydroxylase involved in collagen synthesis and localized to the endoplasmic reticulum (77). Mutations in PLOD1 have been associated with type VI Ehlers-Danlos syndrome, a genetic disorder caused by defects in collagen synthesis (78). In another example, microRNA-target predictions from TargetScan were analyzed and validated HIF targets were enriched for five microRNAs including miR-1/206 and miR-130/301. miR-1/206 were shown to be upregulated in a rat model of myocardial infarction (79) and miR-130 was shown to regulate angiogenesis (80). Both are relevant to the HIF pathway and would be attractive candidate microRNAs to study further with respect to the validated and predicted targets. Finally, protein interaction data presented in Figure 4C can be used to identify potential regulators, co-factors or adapter proteins that play a role in the HIF pathway. Finally, P300/CBP-associated factor (PCAF) interacts with four validated HIF targets and six predicted targets. PCAF was previously shown to be a HIF-1alpha co-factor that regulates p53-transcriptional activity in hypoxia (81). The specific HIF targets that interact with PCAF are attractive candidates for functional studies.
###end p 74
###begin p 75
###xml 466 469 466 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EPO</italic>
###xml 524 527 524 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EPO</italic>
###xml 619 622 619 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EPO</italic>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B82">82</xref>
###xml 867 872 867 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B83">83</xref>
###xml 1026 1030 1026 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHD3</italic>
###xml 1033 1035 1033 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B84">84</xref>
###xml 1063 1065 1063 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B85">85</xref>
The method presented here is not without limitation. First, the microarray itself presents a limitation since only genes represented on the microarray are considered. However, this could be improved by using multiple platforms that offer complete coverage of annotated genes. Of the 86 previously validated HIF-1 targets (), only 56 responded to hypoxia in at least one cell type. One example of a bona fide HIF-target gene that was not recovered by our analysis is EPO (erythropoietin). A close examination of the data for EPO revealed that the probe did not respond to hypoxia in any of the cells that were profiled. EPO was previously reported to be highly induced in the kidney (82). Second, HIF-binding sites may be located outside the promoter region we defined or may not be conserved in other species. The binding site for the well-characterized HIF-1 target VEGFA is located at -985 bp (83) and therefore was not recovered in the present analysis. HIF-1-binding sites have been identified as far as 12-kb downstream (PHD3, (84) and 5-kb upstream [eNos; (85)] of the TSS. The defined promoter region was found optimal to capture most of the known sites (60% of known HIF-1-binding sites) while minimizing potential false positive prediction.
###end p 75
###begin p 76
###xml 753 758 753 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EDEM3</italic>
###xml 835 837 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B86">86</xref>
###xml 1005 1007 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B87">87</xref>
###xml 1350 1352 1346 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B88">88</xref>
###xml 1454 1456 1450 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B89">89</xref>
###xml 1282 1287 <span type="species:ncbi:4932">yeast</span>
In this study we provide a ranked catalogue of genes predicted to be direct HIF-target genes. Given the different hypoxia response between cell types, it is currently difficult to estimate how many HIF-target genes exist. Our analysis across six cell types was stringent in an effort to obtain the highest specificity and the top 200 ranked genes are of high confidence. The ranking system by itself offers a level of confidence for the prediction and was shown as reliable by high ranking for previously validated targets (). Currently, almost all known HIF-target genes are upregulated in hypoxia. While the majority of predicted HIF targets were upregulated in hypoxia, nearly all downregulated genes are novel. The top ranking downregulated gene is EDEM3, an alpha1,2-mannosidase involved in quality control of misfolded proteins (86). In addition, a subset of downregulated genes highlighted in the mitochondrial map is consistent with the observed attenuation of oxidative phosphorylation by HIF-1 (87). We also identified NF-Y as significantly co-occurring adjacent to the highest scoring HIF-1 site in four of these downregulated mitochondrial genes. It is currently unclear whether NF-Y is part of the hypoxic regulation of those genes. However, it was previously shown in yeast that the NF-Y homolog regulates the mitochondrial enzyme COX (88), which was also shown to be regulated by HIF-1 to optimize efficiency of mitochondrial respiration (89).
###end p 76
###begin p 77
###xml 339 344 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CREB1</italic>
###xml 346 350 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATF2</italic>
###xml 355 358 353 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP1</italic>
###xml 360 365 358 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B90 B91 B92">90&#8211;92</xref>
###xml 548 552 546 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WSB1</italic>
###xml 634 639 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CREB1</italic>
###xml 641 645 639 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATF6</italic>
###xml 647 651 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATF2</italic>
###xml 656 664 654 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JUN:ATF2</italic>
###xml 731 735 729 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WSB1</italic>
###xml 813 818 811 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIPK2</italic>
###xml 820 822 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B93">93</xref>
###xml 886 888 880 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B94">94</xref>
###xml 891 895 885 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WSB1</italic>
###xml 998 1002 992 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WSB1</italic>
###xml 1108 1112 1098 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WSB1</italic>
###xml 1117 1122 1107 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIPK2</italic>
To describe the transcriptional network of HIF, we identified additional TFBS over-represented within +/-150 bp from the highest scoring HIF site as well as TFBS enriched in the entire promoter. We identified only a few TFs within a specific distance from the HIF site, however, almost all were previously associated with HIF-1, including CREB1, ATF2 and SP1 (90-92). The recovery of these TFs increases the confidence in the genes predicted as HIF targets and also identifies specific gene targets in  as predicted targets with higher confidence. WSB1, for instance, is a novel predicted HIF-1 target that contains binding sites for CREB1, ATF6, ATF2 and JUN:ATF2, a profile very similar to LDHA that is a bona fide HIF-1 target. WSB1 was previously shown to be involved in the ubiquitination and degradation of HIPK2 (93), a kinase that was shown to repress HIF-1alpha transcription (94). WSB1 was also confirmed to be hypoxia responsive by quantitative PCR (). Taken together these data suggest WSB1 is highly likely to be a direct HIF-1 target and to be part of a feedback loop that includes HIF-1alpha, WSB1 and HIPK2. TFs that were previously associated with HIF-1 appear to be enriched only in genes upregulated during hypoxia. YY-1 and NF-Y were detected as enriched in downregulated genes. Further studies will be necessary to validate these observations and to determine their functional relevance to HIF-1.
###end p 77
###begin p 78
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">De-novo</italic>
###xml 357 364 357 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de-novo</italic>
###xml 482 489 482 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de-novo</italic>
###xml 502 507 502 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CREB1</italic>
###xml 509 512 509 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JUN</italic>
###xml 513 517 513 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATF2</italic>
###xml 519 523 519 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATF2</italic>
###xml 525 529 525 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATF6</italic>
###xml 573 580 573 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de-novo</italic>
De-novo motif prediction suggested that no significant information flanking the HIF consensus-binding site could be found in the predicted HIF-target genes. This is consistent with the observation that enhancing the number of validated HIF-binding sites reduces the information content of the flanking nucleotides (). Conservation was not considered in the de-novo prediction process. Yet, several TFs identified as part of the HIF-transcriptional network have also been identified de-novo, including, CREB1, JUN:ATF2, ATF2, ATF6 and AP-1. The ability to recover these TFs de-novo confirms their significant over-representation and demonstrates the utility of this approach in recovering previously validated TFs and co-factor that are part of the HIF network. Furthermore, novel TFs that may be part of the HIF-transcriptional network are currently supported by sequence analysis data alone and additional studies are required to validate these findings.
###end p 78
###begin p 79
HIF-1 and HIF-2 are both key transcription factors with that modulate metabolic pathways, bioenergetics and processes relevant to cancer onset and progression. This study not only gives insights into the genes potentially regulated by HIF but also serves as a guide to study direct targets of other transcription factors.
###end p 79
###begin title 80
SUPPLEMENTARY DATA
###end title 80
###begin p 81
 are available at NAR Online.
###end p 81
###begin title 82
[Supplementary Data]
###end title 82
###begin title 83
[Supplementary Data]
###end title 83
###begin title 84
FUNDING
###end title 84
###begin p 85
###xml 27 56 27 56 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</funding-source>
###xml 71 79 71 79 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DK043351</award-id>
###xml 81 89 81 89 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AI062773</award-id>
###xml 91 98 91 98 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DK83756</award-id>
###xml 121 150 121 150 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</funding-source>
###xml 165 173 165 173 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HG001696</award-id>
###xml 200 229 200 229 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</funding-source>
###xml 244 251 244 251 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CA92594</award-id>
Harris Fellowship to Y.B.; National Institutes of Health [grant number DK043351, AI062773, DK83756] for work in RJX lab; National Institutes of Health [grant number HG001696] for work in MZQ lab; and National Institutes of Health [grant number CA92594] for work in DCC lab. Funding for open access charge: [grant number HG001696, CA45508] for MZQ lab.
###end p 85
###begin p 86
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 86
###begin p 87
Present address: Andrew D. Smith, Department of Biology, University of Southern California, Los Angeles, CA 90089, USA
###end p 87
###begin p 88
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
###end p 88
###begin title 89
REFERENCES
###end title 89
###begin article-title 90
Purification and characterization of hypoxia-inducible factor 1
###end article-title 90
###begin article-title 91
Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
###end article-title 91
###begin article-title 92
The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix
###end article-title 92
###begin article-title 93
Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex
###end article-title 93
###begin article-title 94
Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein
###end article-title 94
###begin article-title 95
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
###end article-title 95
###begin article-title 96
Hypoxia requires notch signaling to maintain the undifferentiated cell state
###end article-title 96
###begin article-title 97
Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
###end article-title 97
###begin article-title 98
HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing
###end article-title 98
###begin article-title 99
Integration of oxygen signaling at the consensus HRE
###end article-title 99
###begin article-title 100
Analysis of hypoxia-inducible factor 1alpha expression and its effects on invasion and metastasis
###end article-title 100
###begin article-title 101
Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression
###end article-title 101
###begin article-title 102
The role of hypoxia-inducible factors in tumorigenesis
###end article-title 102
###begin article-title 103
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma
###end article-title 103
###begin article-title 104
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
###end article-title 104
###begin article-title 105
Targeting HIF-1 for cancer therapy
###end article-title 105
###begin article-title 106
Role of hypoxia-inducible factor-1alpha as a cancer therapy target
###end article-title 106
###begin article-title 107
HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia
###end article-title 107
###begin article-title 108
HIF-1alpha controls keratinocyte proliferation by up-regulating p21(WAF1/Cip1)
###end article-title 108
###begin article-title 109
###xml 71 93 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Roles of the HIF-1 hypoxia-inducible factor during hypoxia response in Caenorhabditis elegans
###end article-title 109
###begin article-title 110
Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways
###end article-title 110
###begin article-title 111
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
###end article-title 111
###begin article-title 112
CisModule: de novo discovery of cis-regulatory modules by hierarchical mixture modeling
###end article-title 112
###begin article-title 113
De novo cis-regulatory module elicitation for eukaryotic genomes
###end article-title 113
###begin article-title 114
###xml 64 69 <span type="species:ncbi:9606">human</span>
Discovering functional transcription-factor combinations in the human cell cycle
###end article-title 114
###begin article-title 115
###xml 45 50 <span type="species:ncbi:9606">human</span>
Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals
###end article-title 115
###begin article-title 116
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
DNA motifs in human and mouse proximal promoters predict tissue-specific expression
###end article-title 116
###begin article-title 117
CORE_TF: a user-friendly interface to identify evolutionary conserved transcription factor binding sites in sets of co-regulated genes
###end article-title 117
###begin article-title 118
Unraveling transcriptional control and cis-regulatory codes using the software suite GeneACT
###end article-title 118
###begin article-title 119
Computational prediction of transcription-factor binding site locations
###end article-title 119
###begin article-title 120
Computational approaches to finding and analyzing cis-regulatory elements
###end article-title 120
###begin article-title 121
Identifying tissue-selective transcription factor binding sites in vertebrate promoters
###end article-title 121
###begin article-title 122
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles
###end article-title 122
###begin article-title 123
Regulatory element detection using correlation with expression
###end article-title 123
###begin article-title 124
Integrating regulatory motif discovery and genome-wide expression analysis
###end article-title 124
###begin article-title 125
Interacting models of cooperative gene regulation
###end article-title 125
###begin article-title 126
NCBI GEO: mining millions of expression profiles - database and tools
###end article-title 126
###begin article-title 127
ArrayExpress - a public database of microarray experiments and gene expression profiles
###end article-title 127
###begin article-title 128
A model based background adjustment for oligonucleotide expression arrays
###end article-title 128
###begin article-title 129
Bioconductor: open software development for computational biology and bioinformatics
###end article-title 129
###begin article-title 130
Use of within-array replicate spots for assessing differential expression in microarray experiments
###end article-title 130
###begin article-title 131
Controlling the false discovery rate: a practical and powerful approach to multiple testing
###end article-title 131
###begin article-title 132
The UCSC Genome Browser Database: 2008 update
###end article-title 132
###begin article-title 133
Statistical significance of cis-regulatory modules
###end article-title 133
###begin article-title 134
The KEGG resource for deciphering the genome
###end article-title 134
###begin article-title 135
Reactome: a knowledge base of biologic pathways and processes
###end article-title 135
###begin article-title 136
###xml 81 86 <span type="species:ncbi:9606">human</span>
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
###end article-title 136
###begin article-title 137
Database resources of the National Center for Biotechnology Information
###end article-title 137
###begin article-title 138
InterPro, progress and status in 2005
###end article-title 138
###begin article-title 139
The Universal Protein Resource (UniProt)
###end article-title 139
###begin article-title 140
The Gene Ontology Annotation (GOA) Database: sharing knowledge in Uniprot with Gene Ontology
###end article-title 140
###begin article-title 141
###xml 29 34 <span type="species:ncbi:9606">human</span>
Systematic identification of human mitochondrial disease genes through integrative genomics
###end article-title 141
###begin article-title 142
Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer
###end article-title 142
###begin article-title 143
Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc
###end article-title 143
###begin article-title 144
###xml 102 107 <span type="species:ncbi:9606">human</span>
Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers
###end article-title 144
###begin article-title 145
Investigating hypoxic tumor physiology through gene expression patterns
###end article-title 145
###begin article-title 146
Hypoxic regulation of mRNA expression
###end article-title 146
###begin article-title 147
Hypoxic condition- and high cell density-induced expression of Redd1 is regulated by activation of hypoxia-inducible factor-1alpha and Sp1 through the phosphatidylinositol 3-kinase/Akt signaling pathway
###end article-title 147
###begin article-title 148
Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis
###end article-title 148
###begin article-title 149
The role of HIF-1 alpha in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia
###end article-title 149
###begin article-title 150
Hypoxic induction of prolyl 4-hydroxylase alpha (I) in cultured cells
###end article-title 150
###begin article-title 151
Hypoxia upregulates the histone demethylase JMJD1A via HIF-1
###end article-title 151
###begin article-title 152
Hypoxia results in an HIF-1-dependent induction of brain-specific aldolase C in lung epithelial cells
###end article-title 152
###begin article-title 153
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
Genome-wide mapping and analysis of active promoters in mouse embryonic stem cells and adult organs
###end article-title 153
###begin article-title 154
Identification of two essential glutamic acid residues in glycogen synthase
###end article-title 154
###begin article-title 155
Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency
###end article-title 155
###begin article-title 156
Ankyrin repeat: a unique motif mediating protein-protein interactions
###end article-title 156
###begin article-title 157
Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH)
###end article-title 157
###begin article-title 158
NF-kappaB regulation in the immune system
###end article-title 158
###begin article-title 159
Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors
###end article-title 159
###begin article-title 160
Modulating hypoxia-inducible transcription by disrupting the HIF-1-DNA interface
###end article-title 160
###begin article-title 161
Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger
###end article-title 161
###begin article-title 162
Hypoxia-associated induction of early growth response-1 gene expression
###end article-title 162
###begin article-title 163
Cell cycle-dependent regulation of pyrimidine biosynthesis
###end article-title 163
###begin article-title 164
Interaction of the U3-55k protein with U3 snoRNA is mediated by the box B/C motif of U3 and the WD repeats of U3-55k
###end article-title 164
###begin article-title 165
Cardiomyopathy and exercise intolerance in muscle glycogen storage disease 0
###end article-title 165
###begin article-title 166
###xml 152 156 <span type="species:ncbi:10090">mice</span>
Tissue-specific changes in the hydroxylysine content and cross-links of collagens and alterations in fibril morphology in lysyl hydroxylase 1 knock-out mice
###end article-title 166
###begin article-title 167
Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK)
###end article-title 167
###begin article-title 168
###xml 45 48 <span type="species:ncbi:10116">rat</span>
Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction
###end article-title 168
###begin article-title 169
Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5
###end article-title 169
###begin article-title 170
PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia
###end article-title 170
###begin article-title 171
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 7 10 <span type="species:ncbi:10116">rat</span>
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
Human, rat, and mouse kidney cells express functional erythropoietin receptors
###end article-title 171
###begin article-title 172
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
###end article-title 172
###begin article-title 173
Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene
###end article-title 173
###begin article-title 174
###xml 50 55 <span type="species:ncbi:9606">human</span>
Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter
###end article-title 174
###begin article-title 175
EDEM3, a soluble EDEM homolog, enhances glycoprotein endoplasmic reticulum-associated degradation and mannose trimming
###end article-title 175
###begin article-title 176
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1
###end article-title 176
###begin article-title 177
###xml 76 81 <span type="species:ncbi:4932">yeast</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
Transcriptional activators HAP/NF-Y rescue a cytochrome c oxidase defect in yeast and human cells
###end article-title 177
###begin article-title 178
HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells
###end article-title 178
###begin article-title 179
CREB binding to the hypoxia-inducible factor-1 responsive elements in the plasminogen activator inhibitor-1 promoter mediates the glucagon effect
###end article-title 179
###begin article-title 180
Molecular mechanism of hypoxia-mediated hepatic gluconeogenesis by transcriptional regulation
###end article-title 180
###begin article-title 181
Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways
###end article-title 181
###begin article-title 182
Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1
###end article-title 182
###begin article-title 183
Transcriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growth
###end article-title 183
###begin article-title 184
###xml 67 72 <span type="species:ncbi:4932">yeast</span>
Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes
###end article-title 184

